<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32614901</article-id>
<article-id pub-id-type="pmc">7332001</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0235512</article-id>
<article-id pub-id-type="publisher-id">PONE-D-20-10849</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Biochemistry</subject>
<subj-group>
<subject>Neurochemistry</subject>
<subj-group>
<subject>Neurotransmitters</subject>
<subj-group>
<subject>Biogenic Amines</subject>
<subj-group>
<subject>Serotonin</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
<subj-group>
<subject>Neurochemistry</subject>
<subj-group>
<subject>Neurotransmitters</subject>
<subj-group>
<subject>Biogenic Amines</subject>
<subj-group>
<subject>Serotonin</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Mathematical and Statistical Techniques</subject>
<subj-group>
<subject>Statistical Methods</subject>
<subj-group>
<subject>Metaanalysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Physical Sciences</subject>
<subj-group>
<subject>Mathematics</subject>
<subj-group>
<subject>Statistics</subject>
<subj-group>
<subject>Statistical Methods</subject>
<subj-group>
<subject>Metaanalysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Developmental Psychology</subject>
<subj-group>
<subject>Pervasive Developmental Disorders</subject>
<subj-group>
<subject>Autism Spectrum Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Social Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Developmental Psychology</subject>
<subj-group>
<subject>Pervasive Developmental Disorders</subject>
<subj-group>
<subject>Autism Spectrum Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>People and places</subject>
<subj-group>
<subject>Population groupings</subject>
<subj-group>
<subject>Ethnicities</subject>
<subj-group>
<subject>Latin American people</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Heredity</subject>
<subj-group>
<subject>Genetic Mapping</subject>
<subj-group>
<subject>Variant Genotypes</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Mood Disorders</subject>
<subj-group>
<subject>Depression</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genetic Loci</subject>
<subj-group>
<subject>Alleles</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Mood Disorders</subject>
<subj-group>
<subject>Bipolar Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The role of 5-HTTLPR in autism spectrum disorder: New evidence and a meta-analysis of this polymorphism in Latin American population with psychiatric disorders</article-title>
<alt-title alt-title-type="running-head">5-HTTLPR polymorphism in Latin American individuals with psychiatric disorders</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nuñez-Rios</surname>
<given-names>D. L.</given-names>
</name>
<role content-type="https://casrai.org/credit/">Methodology</role>
<role content-type="https://casrai.org/credit/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chaskel</surname>
<given-names>R.</given-names>
</name>
<role content-type="https://casrai.org/credit/">Methodology</role>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lopez</surname>
<given-names>A.</given-names>
</name>
<role content-type="https://casrai.org/credit/">Methodology</role>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galeano</surname>
<given-names>L.</given-names>
</name>
<role content-type="https://casrai.org/credit/">Methodology</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2113-9266</contrib-id>
<name>
<surname>Lattig</surname>
<given-names>M. C.</given-names>
</name>
<role content-type="https://casrai.org/credit/">Funding acquisition</role>
<role content-type="https://casrai.org/credit/">Supervision</role>
<role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label>
<addr-line>Departamento de Ciencias Biológicas, Universidad de los Andes, Bogotá, Colombia</addr-line></aff>
<aff id="aff002"><label>2</label>
<addr-line>Instituto Colombiano del Sistema Nervioso Clínica Monserrat, Bogotá, Colombia</addr-line></aff>
<aff id="aff003"><label>3</label>
<addr-line>Fundación Santa Fe de Bogotá, Bogotá, Colombia</addr-line></aff>
<aff id="aff004"><label>4</label>
<addr-line>Servicios Integrales en Genética (SIGEN) alianza Fundación Santa Fe de Bogotá – Universidad de los Andes, Bogotá, Colombia</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Novelli</surname>
<given-names>Giuseppe</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>Universita degli Studi di Roma Tor Vergata, ITALY</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email>mlattig@uniandes.edu.co</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>2</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>15</volume>
<issue>7</issue>
<elocation-id>e0235512</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>4</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>6</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 Nuñez-Rios et al</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Nuñez-Rios et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pone.0235512.pdf"></self-uri>
<abstract>
<p>The autism spectrum disorder (ASD) is a complex disorder encompassing a broad phenotypic and genotypic variability. The short (S)/long (L) 5-HTTLPR polymorphism has a functional role in the regulation of extracellular serotonin levels and both alleles have been associated to ASD. Most studies including European, American, and Asian populations have suggested an ethnical heterogeneity of this polymorphism; however, the short/long frequencies from Latin American population have been under-studied in recent meta-analysis. Here, we evaluated the 5-HTTLPR polymorphism in Colombian individuals with idiopathic ASD and reported a non-preferential S or L transmission and a non-association with ASD risk or symptom severity. Moreover, to recognize the allelic frequencies of an under-represented population we also recovered genetic studies from Latin American individuals and compared these frequencies with frequencies from other ethnicities. Results from meta-analysis suggest that short/long frequencies in Latin American are similar to those reported in Caucasian population but different to African and Asian regions.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>Colciencias-Colombia</institution>
</funding-source>
<award-id>120474455837 (744-2016)</award-id>
<principal-award-recipient>María Claudia Lattig</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>Universidad de Los Andes</institution>
</funding-source>
<award-id>Vicerrectoria de Investigaciones</award-id>
<principal-award-recipient>María Claudia Lattig</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution>Ceiba</institution>
</funding-source>
<award-id>Becas Bogota</award-id>
<principal-award-recipient>Diana Nuñez-Rios</principal-award-recipient>
</award-group>
<funding-statement>MCL: Grant # 120474455837 (744-2016) from Minciencias, previously known as Colciencias MCL: Grant Heterogeneidad Genetica del Autismo. Vicerrectoria de investigaciones -Universidad de Los Andes DLN: scholarship from Ceiba.</funding-statement>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="4"></table-count>
<page-count count="11"></page-count>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>All relevant data are within the paper and its Supporting Information files.</p>
</notes>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by three core symptoms: repetitive/restricted behaviors, impairment in social interaction and variable communication skills [<xref ref-type="bibr" rid="pone.0235512.ref001">1</xref>]. The twin concordance rate and a milder autism phenotype in relatives reflects a strong genetic component in the pathophysiology of ASD; nevertheless, the broad phenotypic variability of this disorder and the 60% of individuals who remain with unknown etiology suggest an interplay of several genetic factors [<xref ref-type="bibr" rid="pone.0235512.ref002">2</xref>–<xref ref-type="bibr" rid="pone.0235512.ref004">4</xref>]</p>
<p>Most of the genetic factors involved in ASD have a role in brain development and the excitatory/inhibitory synaptic balance [<xref ref-type="bibr" rid="pone.0235512.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0235512.ref008">8</xref>]. The serotoninergic system participates in neurogenesis, axon guidance and cell migration, and also modulates GABA and glutamate neurotransmitter release in presynaptic terminals. Within the serotoninergic system, the serotonin re-uptake transporter (SERT) located in presynaptic terminals and encoded by the <italic>SLC6A4</italic> gene (Solute carrier family 6 member 4, Gene ID: 6532) has been widely studied. The transcriptional efficiency of <italic>SLC6A4</italic> is regulated by the well-known short (S)/long (L) 5HTTLPR (5-HTT gene-linked polymorphic region) polymorphism, a repetitive sequence present in the upstream regulatory region of this gene [<xref ref-type="bibr" rid="pone.0235512.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0235512.ref014">14</xref>]. The short allele which reduces the transcriptional activity has been reported with greater frequency in African and Egyptian individuals with ASD [<xref ref-type="bibr" rid="pone.0235512.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0235512.ref016">16</xref>], and has been also associated with other psychiatric disorders such as major depressive disorder [<xref ref-type="bibr" rid="pone.0235512.ref017">17</xref>–<xref ref-type="bibr" rid="pone.0235512.ref020">20</xref>], bipolar disorder [<xref ref-type="bibr" rid="pone.0235512.ref021">21</xref>] and depression risk in Parkinson disease [<xref ref-type="bibr" rid="pone.0235512.ref022">22</xref>] among others; however, conflicting results have been also reported [<xref ref-type="bibr" rid="pone.0235512.ref023">23</xref>–<xref ref-type="bibr" rid="pone.0235512.ref025">25</xref>].</p>
<p>Despite three meta-analysis suggesting that the short/long alleles are not risk factors for ASD [<xref ref-type="bibr" rid="pone.0235512.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0235512.ref028">28</xref>], the ethnical heterogeneity among included studies has been proposed as a factor that may affect the overall result. A comprehensive transmission disequilibrium test (TDT) meta-analysis including eighteen studies from diverse populations, demonstrated a non-preferential S/L transmission at the global scale, but preferential transmission of the S and L alleles in the American and Asian populations, respectively [<xref ref-type="bibr" rid="pone.0235512.ref029">29</xref>]. Thus, based on the frequency differences of 5-HTTLPR polymorphism in the worl-wide population, here we present an attempt to understand the role of short/long allele in Colombian population with idiopathic ASD in terms of risk, preferential transmission and symptoms severity. Additionally, we performed a meta-analysis aiming to evaluate the heterogeneity of the S and L alleles in the under-represented and highly admixed Latin America population.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and methods</title>
<p>The research protocol was approved by ethics committee of participating institutions (Universidad de Los Andes and Instituto Colombiano del Sistema Nervioso—Clínica Montserrat). Written informed consent was obtained by all participants under 16. Parent or legal guardian written consent was obtained for all participants 15 and under or unable to consent.</p>
<sec id="sec003">
<title>Subjects</title>
<p>Idiopathic ASD diagnosis confirmed in 105 individuals was performed using the Diagnostic and Statistical Manual of Mental Disorders V (DSM-V) criteria [<xref ref-type="bibr" rid="pone.0235512.ref001">1</xref>]. Clinical evaluation also included the completion of the ADOS [<xref ref-type="bibr" rid="pone.0235512.ref030">30</xref>,<xref ref-type="bibr" rid="pone.0235512.ref031">31</xref>] and ADI-R [<xref ref-type="bibr" rid="pone.0235512.ref032">32</xref>] instruments. For our case-control analysis we used genotypic information of 171 unrelated and unaffected Colombian individuals belonging to the same region as the ASD trios. Peripheral blood was obtained from all participants and parents. DNA was extracted using Flexigene® DNA kit (Quiagen, Inc).</p>
</sec>
<sec id="sec004">
<title>Genotyping</title>
<p>5-HTTLPR polymorphism was screened through PCR and gel electrophoresis according to Petri S et al., 1996 protocol [<xref ref-type="bibr" rid="pone.0235512.ref033">33</xref>]. PCR product was visualized with 3% MetaPhor agarose gel electrophoresis [Lonza Group Ltd., Basel, Switzerland].</p>
</sec>
<sec id="sec005">
<title>Literature search</title>
<p>The Meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) criteria [<xref ref-type="bibr" rid="pone.0235512.ref034">34</xref>]. We screened without date restriction reports that evaluate the association of 5-HTTLPR and psychiatric disorders in PubMed, ScienceDirect and Scielo databases up to April 2020. To minimize the chance of missing relevant studies the search terms in PubMed and ScienceDirect databases were “HTTLPR” “SLC6A4” AND the name of each country encompassed in South and Central America (each separated by the Boolean operator OR). For the Scielo database, we searched published literature in the indexed journals from Latin American countries (<xref ref-type="supplementary-material" rid="pone.0235512.s008">S1 Fig</xref>). The inclusion criteria were (1) full text article in English or Spanish languages (2) case-control studies evaluating the polymorphism in psychiatric disorders (3) genotypic or allelic frequency provided and (4) control individuals not deviated from Hardy-Weinberg Equilibrium (HWE). We excluded reviews, studies evaluating trios, cases and no controls, population without a clinical diagnosis and studies that did not evaluate the Latin American population or the association of 5-HTTLPR with psychiatric disorders. For articles that did not have all the information available the authors were contacted. The data extraction was carried out by two investigators independently. The collected data from each study was categorized as reference, country of origin, evaluated trait, number of individuals and allelic/genotypic frequencies.</p>
</sec>
<sec id="sec006">
<title>Statistical analysis</title>
<p>The test of association between ASD and 5-HTTLPR polymorphism was evaluated under the allelic (L vs S), genotypic (SS vs SL vs LL), dominant (LL/LS vs SS) and recessive (SS/SL vs LL) models using the genotypic information of 105 individuals with ASD and 171 unaffected/unrelated controls; corrections were conducted by the Bonferroni method. Linear regression and quantitative trait association modeled the severity of common ASD traits as a function of the 5-HTTLPR genotype. The family-based association for the 5-HTTLPR genotype and ASD was evaluated with the transmission disequilibrium test (TDT) using genotypic information of 105 trios. For the meta-analysis, the allelic and genotypic frequencies were included as a common measure to evaluate the association between 5-HTTLPR polymorphism and psychiatric disorders in Latin American population. The heterogeneity across studies was estimated by the Cochran’s Q test and the pooled Odds Ratio (OR) was evaluated under allelic (L vs S) and genotypic (SS vs LL+LS)—(LL vs SS+SL) models with fixed-effect or random-effect models according to I<sup>2</sup> value (Fixed-effect for I<sup>2</sup> &lt;50% and Random-effect for I<sup>2</sup> &gt; 50%). The publication bias was assessed with funnel plots and quantitatively evaluated with Egger’s regression and Begg’s rank correlation. The trim and fill method was used to estimate potential missing studies and the sensitivity analysis removing each study for every meta-analysis was conducted to evaluate the stability of the results. All statistical analysis were performed with PLINK [<xref ref-type="bibr" rid="pone.0235512.ref035">35</xref>] and R studio program [<xref ref-type="bibr" rid="pone.0235512.ref036">36</xref>].</p>
</sec>
</sec>
<sec id="sec007" sec-type="results">
<title>Results</title>
<p>The genotyping results of 105 trios and 171 unrelated controls are described in <xref ref-type="supplementary-material" rid="pone.0235512.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0235512.s002">S2</xref> Tables. The genotypic and allelic frequencies are summarized in <xref ref-type="table" rid="pone.0235512.t001">Table 1</xref> and full sample analysis including families and unrelated controls were consistent with frequencies predicted by Hardy-Weinberg equilibrium (<italic>p</italic> = 0.12).</p>
<table-wrap id="pone.0235512.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0235512.t001</object-id>
<label>Table 1</label>
<caption>
<title>5-HTTLPR polymorphism in Colombian individuals.</title>
</caption>
<alternatives>
<graphic id="pone.0235512.t001g" xlink:href="pone.0235512.t001"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="2">Group</th>
<th align="center" colspan="4" rowspan="1">Genotype frequency</th>
<th align="center" colspan="2" rowspan="1">Allele frequency</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1">LL</th>
<th align="center" colspan="1" rowspan="1">SL</th>
<th align="center" colspan="1" rowspan="1">SS</th>
<th align="center" colspan="1" rowspan="1">Total</th>
<th align="center" colspan="1" rowspan="1">L</th>
<th align="center" colspan="1" rowspan="1">S</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>Father</bold>
</td>
<td align="center" colspan="1" rowspan="1">19 [18%]</td>
<td align="center" colspan="1" rowspan="1">49 [47%]</td>
<td align="center" colspan="1" rowspan="1">37 [35%]</td>
<td align="center" colspan="1" rowspan="1">105</td>
<td align="char" char="." colspan="1" rowspan="1">0.41</td>
<td align="char" char="." colspan="1" rowspan="1">0.59</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>Mother</bold>
</td>
<td align="center" colspan="1" rowspan="1">23 [22%]</td>
<td align="center" colspan="1" rowspan="1">42 [40%]</td>
<td align="center" colspan="1" rowspan="1">40 [38%]</td>
<td align="center" colspan="1" rowspan="1">105</td>
<td align="char" char="." colspan="1" rowspan="1">0.42</td>
<td align="char" char="." colspan="1" rowspan="1">0.58</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>Child with ASD</bold>
</td>
<td align="center" colspan="1" rowspan="1">22 [21%]</td>
<td align="center" colspan="1" rowspan="1">42 [40%]</td>
<td align="center" colspan="1" rowspan="1">41 [39%]</td>
<td align="center" colspan="1" rowspan="1">105</td>
<td align="char" char="." colspan="1" rowspan="1">0.41</td>
<td align="char" char="." colspan="1" rowspan="1">0.59</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>Unrelated controls</bold>
</td>
<td align="center" colspan="1" rowspan="1">38 [22%]</td>
<td align="center" colspan="1" rowspan="1">89 [52%]</td>
<td align="center" colspan="1" rowspan="1">44 [26%]</td>
<td align="center" colspan="1" rowspan="1">171</td>
<td align="char" char="." colspan="1" rowspan="1">0.48</td>
<td align="char" char="." colspan="1" rowspan="1">0.52</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001">
<p>Genotypic and allelic frequencies in ASD trios and unaffected individuals</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Although a significant association between 5-HTTLPR and ASD was observed only under dominant model (SS vs SL+LL, (<italic>p</italic> = 0.022)) (<xref ref-type="supplementary-material" rid="pone.0235512.s003">S3 Table</xref>), after Bonferroni’s correction non-significant result was observed. Additionally, the transmission disequilibrium test (TDT) indicates a non-preferential transmission of either the short or long allele (χ<sup>2</sup> = 0.0989, <italic>p</italic> = 0.75) (<xref ref-type="supplementary-material" rid="pone.0235512.s004">S4 Table</xref>).</p>
<p>Phenotypic features and comorbidities in individuals with ASD were analyzed according to genotype (<xref ref-type="supplementary-material" rid="pone.0235512.s005">S5 Table</xref>). Aggressive behaviors were the most common comorbidity reported followed by intellectual disability and epilepsy. The sex ratio was 6:1 (male-to-female) with mean age of 10,8 ± 7,8 years old. For reasons of statistical power, the analysis between 5-HTTLPR and autism severity was restricted to the three core ASD symptoms (<xref ref-type="supplementary-material" rid="pone.0235512.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0235512.s002">S2</xref> Tables). The mean score for each trait was similar among the three genotypes and statistical test confirmed a non-association (<xref ref-type="table" rid="pone.0235512.t002">Table 2</xref>).</p>
<table-wrap id="pone.0235512.t002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0235512.t002</object-id>
<label>Table 2</label>
<caption>
<title>Phenotypic traits.</title>
</caption>
<alternatives>
<graphic id="pone.0235512.t002g" xlink:href="pone.0235512.t002"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1">ADOS score in investigated dimension [Mean ± SD]</th>
<th align="center" colspan="1" rowspan="1">SS</th>
<th align="center" colspan="1" rowspan="1">SL</th>
<th align="center" colspan="1" rowspan="1">LL</th>
<th align="center" colspan="1" rowspan="1"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">ADOS Social communication</td>
<td align="center" colspan="1" rowspan="1">5,6 ± 1,9</td>
<td align="center" colspan="1" rowspan="1">5,9 ± 1,8</td>
<td align="center" colspan="1" rowspan="1">5 ± 1,8</td>
<td align="char" char="." colspan="1" rowspan="1">0.4936</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ADOS Restricted/Repetitive behaviors</td>
<td align="center" colspan="1" rowspan="1">2,9 ± 1,6</td>
<td align="center" colspan="1" rowspan="1">2,8 ± 1,3</td>
<td align="center" colspan="1" rowspan="1">2,9 ± 1,6</td>
<td align="char" char="." colspan="1" rowspan="1">0.964</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ADOS Social interaction</td>
<td align="center" colspan="1" rowspan="1">8,4 ± 3</td>
<td align="center" colspan="1" rowspan="1">9 ± 2,7</td>
<td align="center" colspan="1" rowspan="1">8,2 ± 2,4</td>
<td align="char" char="." colspan="1" rowspan="1">0.8907</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001">
<p>Mean score and standard deviation to each trait is presented according to genotype.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>A total of 52 publications with the keywords provided in PubMed database were initially filtered, but only 13 case-control studies met the inclusion criteria: two from Colombia, three from Mexico, one from Argentina and seven from Brazil. In ScienceDirect database we found an additional study from Brazil and in Scielo database we found four additional studies: two from Colombia, one from Mexico and one from Brazil. No response was obtained from the authors that were contacted. Thus, from a total of 112 filtered reports, only 18 fulfilled the inclusion criteria (<xref ref-type="supplementary-material" rid="pone.0235512.s008">S1 Fig</xref>), and the allelic frequencies of each study were separately registered for cases and controls (<xref ref-type="table" rid="pone.0235512.t003">Table 3</xref>).</p>
<table-wrap id="pone.0235512.t003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0235512.t003</object-id>
<label>Table 3</label>
<caption>
<title>Allelic frequencies reported in Latin American population.</title>
</caption>
<alternatives>
<graphic id="pone.0235512.t003g" xlink:href="pone.0235512.t003"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="2">Country</th>
<th align="center" colspan="1" rowspan="2">Trait</th>
<th align="center" colspan="3" rowspan="1">Cases</th>
<th align="center" colspan="3" rowspan="1">Controls</th>
<th align="center" colspan="1" rowspan="2">Reference</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1">Sample size</th>
<th align="center" colspan="1" rowspan="1">S</th>
<th align="center" colspan="1" rowspan="1">L</th>
<th align="center" colspan="1" rowspan="1">Sample size</th>
<th align="center" colspan="1" rowspan="1">S</th>
<th align="center" colspan="1" rowspan="1">L</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">Colombia</td>
<td align="center" colspan="1" rowspan="1">ASD</td>
<td align="center" colspan="1" rowspan="1">105</td>
<td align="char" char="." colspan="1" rowspan="1">0.59</td>
<td align="char" char="." colspan="1" rowspan="1">0.41</td>
<td align="center" colspan="1" rowspan="1">171</td>
<td align="char" char="." colspan="1" rowspan="1">0.52</td>
<td align="char" char="." colspan="1" rowspan="1">0.48</td>
<td align="center" colspan="1" rowspan="1">Present study</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Colombia</td>
<td align="center" colspan="1" rowspan="1">Bipolar disorder</td>
<td align="center" colspan="1" rowspan="1">103</td>
<td align="char" char="." colspan="1" rowspan="1">0.49</td>
<td align="char" char="." colspan="1" rowspan="1">0.51</td>
<td align="center" colspan="1" rowspan="1">112</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="char" char="." colspan="1" rowspan="1">0.47</td>
<td align="center" colspan="1" rowspan="1">[Ospina-Duque et al., 2000] [<xref ref-type="bibr" rid="pone.0235512.ref037">37</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Colombia</td>
<td align="center" colspan="1" rowspan="1">MDD</td>
<td align="center" colspan="1" rowspan="1">68</td>
<td align="char" char="." colspan="1" rowspan="1">0.49</td>
<td align="char" char="." colspan="1" rowspan="1">0.51</td>
<td align="center" colspan="1" rowspan="1">68</td>
<td align="char" char="." colspan="1" rowspan="1">0.45</td>
<td align="char" char="." colspan="1" rowspan="1">0.55</td>
<td align="center" colspan="1" rowspan="1">[Pérez-Olmos, et al., 2016] [<xref ref-type="bibr" rid="pone.0235512.ref038">38</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Colombia</td>
<td align="center" colspan="1" rowspan="1">Bipolar disorder</td>
<td align="center" colspan="1" rowspan="1">133</td>
<td align="char" char="." colspan="1" rowspan="1">0.55</td>
<td align="char" char="." colspan="1" rowspan="1">0.45</td>
<td align="center" colspan="1" rowspan="1">120</td>
<td align="char" char="." colspan="1" rowspan="1">0.59</td>
<td align="char" char="." colspan="1" rowspan="1">0.41</td>
<td align="center" colspan="1" rowspan="1">[Ramos, et al., 2012] [<xref ref-type="bibr" rid="pone.0235512.ref039">39</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Colombia</td>
<td align="center" colspan="1" rowspan="1">MDD</td>
<td align="center" colspan="1" rowspan="1">59</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="char" char="." colspan="1" rowspan="1">0.47</td>
<td align="center" colspan="1" rowspan="1">59</td>
<td align="char" char="." colspan="1" rowspan="1">0.44</td>
<td align="char" char="." colspan="1" rowspan="1">0.56</td>
<td align="center" colspan="1" rowspan="1">[Escobar, et al., 2011] [<xref ref-type="bibr" rid="pone.0235512.ref040">40</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Mexico</td>
<td align="center" colspan="1" rowspan="1">Obsessive‐compulsive disorder</td>
<td align="center" colspan="1" rowspan="1">115</td>
<td align="char" char="." colspan="1" rowspan="1">0.58</td>
<td align="char" char="." colspan="1" rowspan="1">0.42</td>
<td align="center" colspan="1" rowspan="1">136</td>
<td align="char" char="." colspan="1" rowspan="1">0.52</td>
<td align="char" char="." colspan="1" rowspan="1">0.48</td>
<td align="center" colspan="1" rowspan="1">[Camarena et al., 2001] [<xref ref-type="bibr" rid="pone.0235512.ref041">41</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Mexico</td>
<td align="center" colspan="1" rowspan="1">MDD</td>
<td align="center" colspan="1" rowspan="1">104</td>
<td align="char" char="." colspan="1" rowspan="1">0.52</td>
<td align="char" char="." colspan="1" rowspan="1">0.48</td>
<td align="center" colspan="1" rowspan="1">335</td>
<td align="char" char="." colspan="1" rowspan="1">0.60</td>
<td align="char" char="." colspan="1" rowspan="1">0.40</td>
<td align="center" colspan="1" rowspan="1">[Peralta-Leal et al., 2012] [<xref ref-type="bibr" rid="pone.0235512.ref042">42</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Mexico</td>
<td align="center" colspan="1" rowspan="1">ADHD</td>
<td align="center" colspan="1" rowspan="1">78</td>
<td align="char" char="." colspan="1" rowspan="1">0.43</td>
<td align="char" char="." colspan="1" rowspan="1">0.57</td>
<td align="center" colspan="1" rowspan="1">56</td>
<td align="char" char="." colspan="1" rowspan="1">0.55</td>
<td align="char" char="." colspan="1" rowspan="1">0.45</td>
<td align="center" colspan="1" rowspan="1">[Durán-González et al., 2018] [<xref ref-type="bibr" rid="pone.0235512.ref043">43</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Mexico</td>
<td align="center" colspan="1" rowspan="1">MDD and suicide attempt</td>
<td align="center" colspan="1" rowspan="1">200</td>
<td align="char" char="." colspan="1" rowspan="1">0.63</td>
<td align="char" char="." colspan="1" rowspan="1">0.37</td>
<td align="center" colspan="1" rowspan="1">233</td>
<td align="char" char="." colspan="1" rowspan="1">0.51</td>
<td align="char" char="." colspan="1" rowspan="1">0.49</td>
<td align="center" colspan="1" rowspan="1">[Sarmiento-Hernandez et al., 2019] [<xref ref-type="bibr" rid="pone.0235512.ref044">44</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Argentina</td>
<td align="center" colspan="1" rowspan="1">MDD</td>
<td align="center" colspan="1" rowspan="1">95</td>
<td align="char" char="." colspan="1" rowspan="1">0.51</td>
<td align="char" char="." colspan="1" rowspan="1">0.49</td>
<td align="center" colspan="1" rowspan="1">107</td>
<td align="char" char="." colspan="1" rowspan="1">0.47</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="center" colspan="1" rowspan="1">[Cajal et al., 2012] [<xref ref-type="bibr" rid="pone.0235512.ref045">45</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Bipolar Disorder</td>
<td align="center" colspan="1" rowspan="1">167</td>
<td align="char" char="." colspan="1" rowspan="1">0.37</td>
<td align="char" char="." colspan="1" rowspan="1">0.63</td>
<td align="center" colspan="1" rowspan="1">184</td>
<td align="char" char="." colspan="1" rowspan="1">0.36</td>
<td align="char" char="." colspan="1" rowspan="1">0.64</td>
<td align="center" colspan="1" rowspan="1">[Neves et al., 2008] [<xref ref-type="bibr" rid="pone.0235512.ref046">46</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Schizophrenia<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="center" colspan="1" rowspan="1">39</td>
<td align="char" char="." colspan="1" rowspan="1">0.42</td>
<td align="char" char="." colspan="1" rowspan="1">0.58</td>
<td align="center" colspan="1" rowspan="1">98</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char="." colspan="1" rowspan="1">0.62</td>
<td align="center" colspan="1" rowspan="1">[Mendes De Oliveira et al., 1998] [<xref ref-type="bibr" rid="pone.0235512.ref047">47</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Bipolar Disorder<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="center" colspan="1" rowspan="1">47</td>
<td align="char" char="." colspan="1" rowspan="1">0.40</td>
<td align="char" char="." colspan="1" rowspan="1">0.60</td>
<td align="center" colspan="1" rowspan="1">98</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char="." colspan="1" rowspan="1">0.62</td>
<td align="center" colspan="1" rowspan="1">[Mendes De Oliveira et al., 1998] [<xref ref-type="bibr" rid="pone.0235512.ref047">47</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Dysthimia<xref ref-type="table-fn" rid="t003fn003">~</xref></td>
<td align="center" colspan="1" rowspan="1">62</td>
<td align="char" char="." colspan="1" rowspan="1">0.43</td>
<td align="char" char="." colspan="1" rowspan="1">0.57</td>
<td align="center" colspan="1" rowspan="1">197</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char="." colspan="1" rowspan="1">0.62</td>
<td align="center" colspan="1" rowspan="1">[Oliveira et al., 2000] [<xref ref-type="bibr" rid="pone.0235512.ref048">48</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Bipolar disorder<xref ref-type="table-fn" rid="t003fn003">~</xref></td>
<td align="center" colspan="1" rowspan="1">64</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char="." colspan="1" rowspan="1">0.62</td>
<td align="center" colspan="1" rowspan="1">197</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char="." colspan="1" rowspan="1">0.62</td>
<td align="center" colspan="1" rowspan="1">[Oliveira et al., 2000] [<xref ref-type="bibr" rid="pone.0235512.ref048">48</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">MDD<xref ref-type="table-fn" rid="t003fn003">~</xref></td>
<td align="center" colspan="1" rowspan="1">66</td>
<td align="char" char="." colspan="1" rowspan="1">0.42</td>
<td align="char" char="." colspan="1" rowspan="1">0.58</td>
<td align="center" colspan="1" rowspan="1">197</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char="." colspan="1" rowspan="1">0.62</td>
<td align="center" colspan="1" rowspan="1">[Oliveira et al., 2000] [<xref ref-type="bibr" rid="pone.0235512.ref048">48</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Anxiety</td>
<td align="center" colspan="1" rowspan="1">129</td>
<td align="char" char="." colspan="1" rowspan="1">0.43</td>
<td align="char" char="." colspan="1" rowspan="1">0.57</td>
<td align="center" colspan="1" rowspan="1">96</td>
<td align="char" char="." colspan="1" rowspan="1">0.43</td>
<td align="char" char="." colspan="1" rowspan="1">0.57</td>
<td align="center" colspan="1" rowspan="1">[Bortoluzzi et al., 2014] [<xref ref-type="bibr" rid="pone.0235512.ref049">49</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Suicide in depressed patients</td>
<td align="center" colspan="1" rowspan="1">84</td>
<td align="char" char="." colspan="1" rowspan="1">0.48</td>
<td align="char" char="." colspan="1" rowspan="1">0.52</td>
<td align="center" colspan="1" rowspan="1">152</td>
<td align="char" char="." colspan="1" rowspan="1">0.44</td>
<td align="char" char="." colspan="1" rowspan="1">0.56</td>
<td align="center" colspan="1" rowspan="1">[Segal, et al, 2006] [<xref ref-type="bibr" rid="pone.0235512.ref050">50</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Epilepsy</td>
<td align="center" colspan="1" rowspan="1">175</td>
<td align="char" char="." colspan="1" rowspan="1">0.47</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="center" colspan="1" rowspan="1">155</td>
<td align="char" char="." colspan="1" rowspan="1">0.45</td>
<td align="char" char="." colspan="1" rowspan="1">0.55</td>
<td align="center" colspan="1" rowspan="1">[Schenkel et al., 2011] [<xref ref-type="bibr" rid="pone.0235512.ref051">51</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">ASD</td>
<td align="center" colspan="1" rowspan="1">151</td>
<td align="char" char="." colspan="1" rowspan="1">0.44</td>
<td align="char" char="." colspan="1" rowspan="1">0.56</td>
<td align="center" colspan="1" rowspan="1">179</td>
<td align="char" char="." colspan="1" rowspan="1">0.45</td>
<td align="char" char="." colspan="1" rowspan="1">0.55</td>
<td align="center" colspan="1" rowspan="1">[Longo, et al, 2009] [<xref ref-type="bibr" rid="pone.0235512.ref052">52</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Schizophrenia—Bipolar disorder</td>
<td align="center" colspan="1" rowspan="1">99</td>
<td align="char" char="." colspan="1" rowspan="1">0.40</td>
<td align="char" char="." colspan="1" rowspan="1">0.60</td>
<td align="center" colspan="1" rowspan="1">60</td>
<td align="char" char="." colspan="1" rowspan="1">0.47</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="center" colspan="1" rowspan="1">[Krelling et al., 2008] [<xref ref-type="bibr" rid="pone.0235512.ref053">53</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Brazil</td>
<td align="center" colspan="1" rowspan="1">Obsessive‐compulsive disorder</td>
<td align="center" colspan="1" rowspan="1">78</td>
<td align="char" char="." colspan="1" rowspan="1">0.54</td>
<td align="char" char="." colspan="1" rowspan="1">0.46</td>
<td align="center" colspan="1" rowspan="1">202</td>
<td align="char" char="." colspan="1" rowspan="1">0.52</td>
<td align="char" char="." colspan="1" rowspan="1">0.48</td>
<td align="center" colspan="1" rowspan="1">[Meira-Lima et al., 2004] [<xref ref-type="bibr" rid="pone.0235512.ref054">54</xref>]</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001">
<p>ASD: Autism Spectrum Disorder, MDD: Major Depressive Disorder, ADHD: Attention Deficit Hyperactivity Disorder.</p>
</fn>
<fn id="t003fn002">
<p>*Two traits evaluated independently but using the same control group,</p>
</fn>
<fn id="t003fn003">
<p><sup>~</sup>Three traits evaluated independently but using the same control group</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The Latin American meta-analysis performed under three models (S vs L), (SS vs SL+LL) and (LL vs SL+SS) reflected a heterogeneity of 33.1%, 19.5% and 13.7%, respectively (<xref ref-type="table" rid="pone.0235512.t004">Table 4</xref>, <xref ref-type="fig" rid="pone.0235512.g001">Fig 1</xref> and <xref ref-type="supplementary-material" rid="pone.0235512.s009">S2 Fig</xref>). Fixed-effect model was selected to estimate the pooled OR based on heterogeneity results. The overall OR in either of the three models failed to find significant association (<xref ref-type="table" rid="pone.0235512.t004">Table 4</xref>) suggesting that the 5-HTTLPR polymorphism does not increase the risk for psychiatric disorders in Latin American population (<xref ref-type="fig" rid="pone.0235512.g001">Fig 1</xref> and <xref ref-type="supplementary-material" rid="pone.0235512.s009">S2 Fig</xref>). For publication bias, the funnel plots suggested absence of a bias (<xref ref-type="supplementary-material" rid="pone.0235512.s010">S3 Fig</xref>) and both Egger´s and Begg’s test confirmed non significance (<xref ref-type="table" rid="pone.0235512.t004">Table 4</xref>). The trim and fill method did not identified missing studies for each model (<xref ref-type="supplementary-material" rid="pone.0235512.s011">S4 Fig</xref>) and the recalculated OR did not yield different conclusions (<xref ref-type="table" rid="pone.0235512.t004">Table 4</xref>) just like the sensitivity analysis (<xref ref-type="supplementary-material" rid="pone.0235512.s006">S6 Table</xref>).</p>
<fig id="pone.0235512.g001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0235512.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Meta-analysis evaluating 5-HTTLPR polymorphism in Latin American population.</title>
<p>Forest plot for the allelic model. The trait and country for each study are found in <xref ref-type="table" rid="pone.0235512.t003">Table 3</xref>. The forest plots for other two models are found in <xref ref-type="supplementary-material" rid="pone.0235512.s009">S2 Fig</xref>.</p>
</caption>
<graphic xlink:href="pone.0235512.g001"></graphic>
</fig>
<table-wrap id="pone.0235512.t004" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0235512.t004</object-id>
<label>Table 4</label>
<caption>
<title>Results of meta-analysis.</title>
</caption>
<alternatives>
<graphic id="pone.0235512.t004g" xlink:href="pone.0235512.t004"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="2">Genetic model</th>
<th align="center" colspan="2" rowspan="1">Meta-analysis</th>
<th align="center" colspan="2" rowspan="1">Heterogeneity</th>
<th align="center" colspan="2" rowspan="1">Bias</th>
<th align="center" colspan="2" rowspan="1">Recalculated OR with trim and fill method</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1">Pooled OR (95% CI)</th>
<th align="center" colspan="1" rowspan="1"><italic>p</italic> Value</th>
<th align="center" colspan="1" rowspan="1">I<sup>2</sup></th>
<th align="center" colspan="1" rowspan="1">p Value</th>
<th align="center" colspan="1" rowspan="1">Egger <italic>p</italic> value</th>
<th align="center" colspan="1" rowspan="1">Begg <italic>p</italic> value</th>
<th align="center" colspan="1" rowspan="1">Pooled OR (95% CI)</th>
<th align="center" colspan="1" rowspan="1"><italic>p</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">S vs L</td>
<td align="center" colspan="1" rowspan="1">1.0698 [0.9880; 1.1584]</td>
<td align="center" colspan="1" rowspan="1">0.0962</td>
<td align="char" char="." colspan="1" rowspan="1">33.1%</td>
<td align="char" char="." colspan="1" rowspan="1">0.0673</td>
<td align="char" char="." colspan="1" rowspan="1">0.5125</td>
<td align="char" char="." colspan="1" rowspan="1">0.9775</td>
<td align="center" colspan="1" rowspan="1">1.0625 [0.9593; 1.1769]</td>
<td align="char" char="." colspan="1" rowspan="1">0.2306</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">SS vs SL+LL</td>
<td align="center" colspan="1" rowspan="1">1.1008 [0.9644; 1.2565]</td>
<td align="center" colspan="1" rowspan="1">0.1548</td>
<td align="char" char="." colspan="1" rowspan="1">19,5%</td>
<td align="char" char="." colspan="1" rowspan="1">0.2034</td>
<td align="char" char="." colspan="1" rowspan="1">0.5359</td>
<td align="char" char="." colspan="1" rowspan="1">0.7997</td>
<td align="center" colspan="1" rowspan="1">1.0913 [0.9355; 1.2730]</td>
<td align="char" char="." colspan="1" rowspan="1">0.2513</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">LL vs SL+SS</td>
<td align="center" colspan="1" rowspan="1">0.9146 [0.8066; 1.0371]</td>
<td align="center" colspan="1" rowspan="1">0.1641</td>
<td align="char" char="." colspan="1" rowspan="1">13,7%</td>
<td align="char" char="." colspan="1" rowspan="1">0.2766</td>
<td align="char" char="." colspan="1" rowspan="1">0.636</td>
<td align="char" char="." colspan="1" rowspan="1">0.8435</td>
<td align="center" colspan="1" rowspan="1">0.9218 [0.7975; 1.0654]</td>
<td align="char" char="." colspan="1" rowspan="1">0.2550</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec008" sec-type="conclusions">
<title>Discussion</title>
<p>The serotonin re-uptake transporter (SERT) located in presynaptic neuron removes this neurotransmitter from the synaptic cleft, regulates the serotonin concentration in the synapse and controls the magnitude or duration of post-synaptic transmission. Single nucleotide, Indel and VNTR polymorphisms in the <italic>SLC6A4</italic> gene have been implicated in the re-uptake efficiency; for example, the LL genotype of 5HTTLPR polymorphism is related with increased SERT concentration becoming the S carrier variants as a risk factor for psychiatric disorders [<xref ref-type="bibr" rid="pone.0235512.ref016">16</xref>–<xref ref-type="bibr" rid="pone.0235512.ref021">21</xref>,<xref ref-type="bibr" rid="pone.0235512.ref055">55</xref>].</p>
<p>The role of 5-HTTLPR polymorphism in the ASD pathophysiology evaluated through case-control studies and family-based association have reflected conflicting results. For instance, two studies suggested S allele as risk variant for ASD [<xref ref-type="bibr" rid="pone.0235512.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0235512.ref016">16</xref>], while three meta-analysis did not find association [<xref ref-type="bibr" rid="pone.0235512.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0235512.ref028">28</xref>]. We assessed this polymorphism through a case-control approach failing to find association between 5-HTTLPR and idiopathic ASD, and also through a family-based assessment that did not find a preferential transmission of either S or L allele. A previous evaluation of this polymorphism in Colombian individuals with ASD also failed to find a significant association [<xref ref-type="bibr" rid="pone.0235512.ref056">56</xref>].</p>
<p>Phenotypic heterogeneity in ASD has been also studied in relation with the 5-HTTLPR polymorphism, two reports suggested an association of the S allele with higher severity in social communication impairment [<xref ref-type="bibr" rid="pone.0235512.ref057">57</xref>,<xref ref-type="bibr" rid="pone.0235512.ref058">58</xref>], while another group associated the severity of this trait with the LL genotype for 5-HTTLPR and the AA genotype for rs25531 [<xref ref-type="bibr" rid="pone.0235512.ref059">59</xref>]. Brune et al., 2006 also reported the LL genotype associated with severity of repetitive behaviors [<xref ref-type="bibr" rid="pone.0235512.ref058">58</xref>]. In our study, we did not find an association between 5-HTTLPR genotype and severity in the three core ASD symptoms (repetitive/restricted behaviors, impairment in social interaction and variable communication skills) just like other three reports [<xref ref-type="bibr" rid="pone.0235512.ref052">52</xref>,<xref ref-type="bibr" rid="pone.0235512.ref060">60</xref>,<xref ref-type="bibr" rid="pone.0235512.ref061">61</xref>]. An association between aggressive behaviors and the serotoninergic system has been also suggested [<xref ref-type="bibr" rid="pone.0235512.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0235512.ref060">60</xref>,<xref ref-type="bibr" rid="pone.0235512.ref062">62</xref>,<xref ref-type="bibr" rid="pone.0235512.ref063">63</xref>]; in our study we observed that self-injury behaviors were mainly reported in individuals with the SS genotype (15/29), and although we did not find a significant association (<italic>p</italic>&gt;0.05) our sample size does not have the statistical power to reveal this association. A summary of these conflicting results is presented in <xref ref-type="supplementary-material" rid="pone.0235512.s007">S7 Table</xref>.</p>
<p>Replication of results across ethnicities has been postulated as a good strategy to discover true risk variants or to understand if the lack of replication reflects the complexity in the genetic architecture of some complex disorders as ASD [<xref ref-type="bibr" rid="pone.0235512.ref064">64</xref>,<xref ref-type="bibr" rid="pone.0235512.ref065">65</xref>]. Although two meta-analyses recovering case-control studies mainly from European, American, and Asian population did not find association of this polymorphism with ASD, they also confirmed high heterogeneity in the included studies probably explained by population ethnicity [<xref ref-type="bibr" rid="pone.0235512.ref027">27</xref>,<xref ref-type="bibr" rid="pone.0235512.ref028">28</xref>]. These results suggest that the 5-HTTLPR polymorphism varies across ethnicities and the genetic background of each population may have a role in the risk conferred by this polymorphism [<xref ref-type="bibr" rid="pone.0235512.ref064">64</xref>,<xref ref-type="bibr" rid="pone.0235512.ref065">65</xref>].</p>
<p>Recognizing the under-representation of Latin American population in studies aimed to understand the role of 5-HTTLPR on worldwide [<xref ref-type="bibr" rid="pone.0235512.ref026">26</xref>,<xref ref-type="bibr" rid="pone.0235512.ref027">27</xref>,<xref ref-type="bibr" rid="pone.0235512.ref029">29</xref>], here we present a meta-analysis including articles which evaluate this polymorphism in Latin American individuals with psychiatric disorders as ASD, bipolar disorder, major depressive disorder, obsessive compulsive disorder, attention deficit hyperactive disorder, schizophrenia, dysthymia, anxiety disorder and suicide [<xref ref-type="bibr" rid="pone.0235512.ref037">37</xref>–<xref ref-type="bibr" rid="pone.0235512.ref054">54</xref>]. Although the S allele has been associated with increased risk for psychiatric disorders [<xref ref-type="bibr" rid="pone.0235512.ref016">16</xref>–<xref ref-type="bibr" rid="pone.0235512.ref021">21</xref>,<xref ref-type="bibr" rid="pone.0235512.ref055">55</xref>], our meta-analysis revealed no significant heterogeneity among studies, no publication bias and failed to find an association between 5-HTTLPR and a risk for psychiatric disorders. Comparing our frequencies with frequencies reported in other continents, the Latin American frequencies are more similar to those reported in Caucasian population [<xref ref-type="bibr" rid="pone.0235512.ref062">62</xref>,<xref ref-type="bibr" rid="pone.0235512.ref066">66</xref>–<xref ref-type="bibr" rid="pone.0235512.ref068">68</xref>], while S allele has been greater in Asian population [<xref ref-type="bibr" rid="pone.0235512.ref069">69</xref>,<xref ref-type="bibr" rid="pone.0235512.ref070">70</xref>] and L allele greater in African population [<xref ref-type="bibr" rid="pone.0235512.ref070">70</xref>,<xref ref-type="bibr" rid="pone.0235512.ref071">71</xref>]. Nevertheless, none of Latin American studies had a strict genetic control for population substructure between cases and controls and according to previous reports the Brazilian population should have an over-representation of African component in some regions [<xref ref-type="bibr" rid="pone.0235512.ref072">72</xref>–<xref ref-type="bibr" rid="pone.0235512.ref074">74</xref>]. Even though Latin America presents a diverse population substructure, most of the regions presented in the meta-analysis are likely to have an elevated Caucasian component compared to native American and African backgrounds [<xref ref-type="bibr" rid="pone.0235512.ref070">70</xref>,<xref ref-type="bibr" rid="pone.0235512.ref075">75</xref>,<xref ref-type="bibr" rid="pone.0235512.ref076">76</xref>]; however, slight differences may not be discarded in some small or separate regions according to demographic history of these admixed countries [<xref ref-type="bibr" rid="pone.0235512.ref072">72</xref>–<xref ref-type="bibr" rid="pone.0235512.ref076">76</xref>].</p>
<p>In summary, our study supports the absence of association between ASD and 5-HTTLPR polymorphism in a homogeneous cohort of Colombian individuals with idiopathic ASD. Additionally, a meta-analysis evaluating this polymorphism in Latin American regions suggests that frequencies of short/long alleles in this under-represented population are relatively homogeneous to frequencies reported in Caucasian populations.</p>
</sec>
<sec id="sec009" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="pone.0235512.s001">
<label>S1 Table</label>
<caption>
<title>Genotyping data for each trio and ADOS score for each individual with idiopathic ASD.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0235512.s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s002">
<label>S2 Table</label>
<caption>
<title>Genotyping data for each unrelated control.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0235512.s002.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s003">
<label>S3 Table</label>
<caption>
<title>Results of case-control association test between ASD and 5-HTTLPR polymorphism.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0235512.s003.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s004">
<label>S4 Table</label>
<caption>
<title>Transmission disequilibrium test in Colombian trios with ASD.</title>
<p>TDT was performed with families having heterozygotes parents (49 fathers and 42 mothers).</p>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0235512.s004.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s005">
<label>S5 Table</label>
<caption>
<title>Phenotypic traits in individuals with ASD according to 5-HTTLPR genotypes.</title>
<p>Two sub-categories were well-thought-out, patients who loss the acquired skills at 2 years old were classified as “ASD with regressive development” and patients with ASD and higher cognitive skills were classified as “High functioning ASD”. Intellectual disability was evaluated during clinical consultation without standardized test. Aggressive behaviors were analyzed according to ADIR reports.</p>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0235512.s005.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s006">
<label>S6 Table</label>
<caption>
<title>Sensitivity analysis.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0235512.s006.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s007">
<label>S7 Table</label>
<caption>
<title>5-HTTLPR polymorphism and ASD severity.</title>
<p>This table summarizes some results of studies evaluating severity of ASD symptoms and the serotoninergic system.</p>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0235512.s007.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s008">
<label>S1 Fig</label>
<caption>
<title>Flowchart for selection of studies in the meta-analysis.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0235512.s008.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s009">
<label>S2 Fig</label>
<caption>
<title>Meta-analysis evaluating 5-HTTLPR in Latin American population.</title>
<p>The trait and country for each study and are in <xref ref-type="table" rid="pone.0235512.t003">Table 3</xref>. a. Forest plot for SS vs SL+LL model, b. Forest plot for LL vs SL+SS model.</p>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0235512.s009.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s010">
<label>S3 Fig</label>
<caption>
<title>Funnel plots to evaluate publication bias.</title>
<p>a. Funnel plot for S vs L model b. Funnel plot for SS vs SL+LL model, c. Funnel plot for LL vs SL+SS model.</p>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0235512.s010.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s011">
<label>S4 Fig</label>
<caption>
<title>Trim and fill funnel plots.</title>
<p>Funnel plots without missing studies a. for S vs L model, b. for SS vs SL+LL model and c. for LL vs SL+SS model.</p>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0235512.s011.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0235512.s012">
<label>S1 Checklist</label>
<caption>
<title>PRISMA checklist.</title>
<p>(DOC)</p>
</caption>
<media xlink:href="pone.0235512.s012.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors are pleased to acknowledge the participant families and Instituto Colombiano del Sistema Nervioso Clínica Monserrat. Special thanks to Silvia Gonzalez Nieves, Daniela Castellanos and Camila Velasco from Universidad de Los Andes.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0235512.ref001">
<label>1</label>
<mixed-citation publication-type="other">American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association. DSM. 2013.</mixed-citation>
</ref>
<ref id="pone.0235512.ref002">
<label>2</label>
<mixed-citation publication-type="journal"><name><surname>D’Abate</surname><given-names>L</given-names></name>, <name><surname>Walker</surname><given-names>S</given-names></name>, <name><surname>Yuen</surname><given-names>RKC</given-names></name>, <name><surname>Tammimies</surname><given-names>K</given-names></name>, <name><surname>Buchanan</surname><given-names>JA</given-names></name>, <name><surname>Davies</surname><given-names>RW</given-names></name>, <etal>et al</etal>
<article-title>Predictive impact of rare genomic copy number variations in siblings of individuals with autism spectrum disorders</article-title>. <source/>Nat Commun [Internet]. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>5519</fpage> Available from: <pub-id pub-id-type="doi">10.1038/s41467-019-13380-2</pub-id>
<pub-id pub-id-type="pmid">31801954</pub-id></mixed-citation>
</ref>
<ref id="pone.0235512.ref003">
<label>3</label>
<mixed-citation publication-type="journal"><name><surname>Rubenstein</surname><given-names>E</given-names></name>, <name><surname>Wiggins</surname><given-names>LD</given-names></name>, <name><surname>Schieve</surname><given-names>LA</given-names></name>, <name><surname>Bradley</surname><given-names>C</given-names></name>, <name><surname>DiGuiseppi</surname><given-names>C</given-names></name>, <name><surname>Moody</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Associations between parental broader autism phenotype and child autism spectrum disorder phenotype in the Study to Explore Early Development</article-title>. <source/>Autism. <year>2019</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref004">
<label>4</label>
<mixed-citation publication-type="journal"><name><surname>Grove</surname><given-names>J</given-names></name>, <name><surname>Ripke</surname><given-names>S</given-names></name>, <name><surname>Als</surname><given-names>TD</given-names></name>, <name><surname>Mattheisen</surname><given-names>M</given-names></name>, <name><surname>Walters</surname><given-names>RK</given-names></name>, <name><surname>Won</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Identification of common genetic risk variants for autism spectrum disorder</article-title>. <source/>Nat Genet. <year>2019</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref005">
<label>5</label>
<mixed-citation publication-type="journal"><name><surname>Satterstrom</surname><given-names>FK</given-names></name>, <name><surname>Kosmicki</surname><given-names>JA</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Breen</surname><given-names>MS</given-names></name>, <name><surname>De Rubeis</surname><given-names>S</given-names></name>, <name><surname>An</surname><given-names>JY</given-names></name>, <etal>et al</etal>
<article-title>Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism</article-title>. <source/>Cell. <year>2020</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref006">
<label>6</label>
<mixed-citation publication-type="journal"><name><surname>Pilorge</surname><given-names>M</given-names></name>, <name><surname>Fassier</surname><given-names>C</given-names></name>, <name><surname>Le Corronc</surname><given-names>H</given-names></name>, <name><surname>Potey</surname><given-names>A</given-names></name>, <name><surname>Bai</surname><given-names>J</given-names></name>, <name><surname>De Gois</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism</article-title>. <source/>Mol Psychiatry. <year>2016</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref007">
<label>7</label>
<mixed-citation publication-type="journal"><name><surname>Satterstrom</surname><given-names>FK</given-names></name>, <name><surname>Kosmicki</surname><given-names>JA</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Breen</surname><given-names>MS</given-names></name>, <name><surname>De Rubeis</surname><given-names>S</given-names></name>, <name><surname>An</surname><given-names>J-Y</given-names></name>, <etal>et al</etal>
<article-title>Novel genes for autism implicate both excitatory and inhibitory cell lineages in risk</article-title>. <source/>bioRxiv. <year>2018</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref008">
<label>8</label>
<mixed-citation publication-type="journal"><name><surname>Doan</surname><given-names>RN</given-names></name>, <name><surname>Lim</surname><given-names>ET</given-names></name>, <name><surname>De Rubeis</surname><given-names>S</given-names></name>, <name><surname>Betancur</surname><given-names>C</given-names></name>, <name><surname>Cutler</surname><given-names>DJ</given-names></name>, <name><surname>Chiocchetti</surname><given-names>AG</given-names></name>, <etal>et al</etal>
<article-title>Recessive gene disruptions in autism spectrum disorder</article-title>. <source/>Nature Genetics. <year>2019</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref009">
<label>9</label>
<mixed-citation publication-type="journal"><name><surname>Heils</surname><given-names>Armin</given-names></name>
<name><surname>Teufel</surname><given-names>Andreas</given-names></name>
<name><surname>Petri</surname><given-names>Susanne</given-names></name>
<name><surname>Stöber</surname><given-names>Gerald</given-names></name>
<name><surname>Riederer</surname><given-names>Peter</given-names></name>
<name><surname>Dietmar</surname><given-names>B</given-names></name>, <name><surname>Heils</surname><given-names>A</given-names></name>, <name><surname>Teufel</surname><given-names>A</given-names></name>, <name><surname>Petri</surname><given-names>S</given-names></name>, <name><surname>Stober</surname><given-names>G</given-names></name>, <name><surname>Riederer</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Allelic variation of human serotonin transporter gene expression</article-title>. <source/>J Neurochem. <year>1996</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref010">
<label>10</label>
<mixed-citation publication-type="journal"><name><surname>Belmer</surname><given-names>A</given-names></name>, <name><surname>Klenowski</surname><given-names>PM</given-names></name>, <name><surname>Patkar</surname><given-names>OL</given-names></name>, <name><surname>Bartlett</surname><given-names>SE</given-names></name>. <article-title>Mapping the connectivity of serotonin transporter immunoreactive axons to excitatory and inhibitory neurochemical synapses in the mouse limbic brain</article-title>. <source/>Brain Struct Funct. <year>2017</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref011">
<label>11</label>
<mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>X</given-names></name>, <name><surname>Kallarackal</surname><given-names>AJ</given-names></name>, <name><surname>Kvarta</surname><given-names>MD</given-names></name>, <name><surname>Goluskin</surname><given-names>S</given-names></name>, <name><surname>Gaylor</surname><given-names>K</given-names></name>, <name><surname>Bailey</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression</article-title>. <source/>Nat Neurosci. <year>2013</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref012">
<label>12</label>
<mixed-citation publication-type="journal"><name><surname>Ciranna</surname><given-names>L</given-names></name>. <article-title>Serotonin as a Modulator of Glutamate- and GABA-Mediated Neurotransmission: Implications in Physiological Functions and in Pathology</article-title>. <source/>Curr Neuropharmacol. <year>2006</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref013">
<label>13</label>
<mixed-citation publication-type="journal"><name><surname>Garbarino</surname><given-names>VR</given-names></name>, <name><surname>Gilman</surname><given-names>TL</given-names></name>, <name><surname>Daws</surname><given-names>LC</given-names></name>, <name><surname>Gould</surname><given-names>GG</given-names></name>. <article-title>Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder</article-title>. <source/>Pharmacological Research. <year>2019</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref014">
<label>14</label>
<mixed-citation publication-type="journal"><name><surname>Muller</surname><given-names>CL</given-names></name>, <name><surname>Anacker</surname><given-names>AMJ</given-names></name>, <name><surname>Veenstra-VanderWeele</surname><given-names>J</given-names></name>. <article-title>The serotonin system in autism spectrum disorder: From biomarker to animal models</article-title>. <source/>Neuroscience. <year>2016</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref015">
<label>15</label>
<mixed-citation publication-type="journal"><name><surname>Gebril</surname><given-names>O</given-names></name>, <name><surname>Khalil</surname><given-names>R</given-names></name>, <name><surname>Meguid</surname><given-names>N</given-names></name>. <article-title>A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children</article-title>. <source/>Adv Biomed Res. <year>2015</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref016">
<label>16</label>
<mixed-citation publication-type="journal"><name><surname>Arieff</surname><given-names>Z</given-names></name>, <name><surname>Kaur</surname><given-names>M</given-names></name>, <name><surname>Gameeldien</surname><given-names>H</given-names></name>, <name><surname>Van Der Merwe</surname><given-names>L</given-names></name>, <name><surname>Bajic</surname><given-names>VB</given-names></name>. <article-title>5-HTTLPR polymorphism: Analysis in South African autistic individuals</article-title>. <source/>Hum Biol. <year>2010</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref017">
<label>17</label>
<mixed-citation publication-type="journal"><name><surname>Culverhouse</surname><given-names>RC</given-names></name>, <name><surname>Saccone</surname><given-names>NL</given-names></name>, <name><surname>Horton</surname><given-names>AC</given-names></name>, <name><surname>Ma</surname><given-names>Y</given-names></name>, <name><surname>Anstey</surname><given-names>KJ</given-names></name>, <name><surname>Banaschewski</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Collaborative meta-Analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression</article-title>. <source/>Mol Psychiatry. <year>2018</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref018">
<label>18</label>
<mixed-citation publication-type="journal"><name><surname>Karg</surname><given-names>K</given-names></name>, <name><surname>Burmeister</surname><given-names>M</given-names></name>, <name><surname>Shedden</surname><given-names>K</given-names></name>, <name><surname>Sen</surname><given-names>S</given-names></name>. <article-title>The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation</article-title>. <source/>Arch Gen Psychiatry. <year>2011</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref019">
<label>19</label>
<mixed-citation publication-type="journal"><name><surname>Ancelin</surname><given-names>ML</given-names></name>, <name><surname>Scali</surname><given-names>J</given-names></name>, <name><surname>Norton</surname><given-names>J</given-names></name>, <name><surname>Ritchie</surname><given-names>K</given-names></name>, <name><surname>Dupuy</surname><given-names>AM</given-names></name>, <name><surname>Chaudieu</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>Heterogeneity in HPA axis dysregulation and serotonergic vulnerability to depression</article-title>. <source/>Psychoneuroendocrinology. <year>2017</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref020">
<label>20</label>
<mixed-citation publication-type="journal"><name><surname>Sharpley</surname><given-names>CF</given-names></name>, <name><surname>Palanisamy</surname><given-names>SKA</given-names></name>, <name><surname>Glyde</surname><given-names>NS</given-names></name>, <name><surname>Dillingham</surname><given-names>PW</given-names></name>, <name><surname>Agnew</surname><given-names>LL</given-names></name>. <article-title>An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings</article-title>. <source/>Behavioural Brain Research. <year>2014</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref021">
<label>21</label>
<mixed-citation publication-type="journal"><name><surname>Jiang</surname><given-names>H yan</given-names></name>, <name><surname>Qiao</surname><given-names>F</given-names></name>, <name><surname>Xu</surname><given-names>X feng</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Bai</surname><given-names>Y</given-names></name>, <name><surname>Jiang</surname><given-names>L ling</given-names></name>. <article-title>Meta-analysis confirms a functional polymorphism (5-HTTLPR) in the serotonin transporter gene conferring risk of bipolar disorder in European populations</article-title>. <source/>Neurosci Lett. <year>2013</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref022">
<label>22</label>
<mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>P</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>5-HTTLPR polymorphism and depression risk in Parkinson’s disease: an updated meta-analysis</article-title>. <source/>Acta Neurol Belg [Internet]. <year>2020</year>; <pub-id pub-id-type="doi">10.1007/s13760-020-01342-1</pub-id></mixed-citation>
</ref>
<ref id="pone.0235512.ref023">
<label>23</label>
<mixed-citation publication-type="journal"><name><surname>Serretti</surname><given-names>A</given-names></name>, <name><surname>Cusin</surname><given-names>C</given-names></name>, <name><surname>Lattuada</surname><given-names>E</given-names></name>, <name><surname>Di Bella</surname><given-names>D</given-names></name>, <name><surname>Catalano</surname><given-names>M</given-names></name>, <name><surname>Smeraldi</surname><given-names>E</given-names></name>. <article-title>Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders</article-title>. <source/>Mol Psychiatry. <year>1999</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref024">
<label>24</label>
<mixed-citation publication-type="journal"><name><surname>Kunugi</surname><given-names>H</given-names></name>, <name><surname>Hattori</surname><given-names>M</given-names></name>, <name><surname>Kato</surname><given-names>T</given-names></name>, <name><surname>Tatsumi</surname><given-names>M</given-names></name>, <name><surname>Sakai</surname><given-names>T</given-names></name>, <name><surname>Sasaki</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Serotonin transporter gene polymorphisms: Ethnic difference and possible association with bipolar affective disorder</article-title>. <source/>Mol Psychiatry. <year>1997</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref025">
<label>25</label>
<mixed-citation publication-type="journal"><name><surname>Fergusson</surname><given-names>DM</given-names></name>, <name><surname>Horwood</surname><given-names>LJ</given-names></name>, <name><surname>Miller</surname><given-names>AL</given-names></name>, <name><surname>Kennedy</surname><given-names>MA</given-names></name>. <article-title>Life stress, 5-HTTLPR and mental disorder: Findings from a 30-year longitudinal study</article-title>. <source/>Br J Psychiatry. <year>2011</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref026">
<label>26</label>
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>PY</given-names></name>, <name><surname>Menga</surname><given-names>YJ</given-names></name>, <name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>. <article-title>Associations of endocrine stress-related gene polymorphisms with risk of autism spectrum disorders: Evidence from an integrated meta-analysis</article-title>. <source/>Autism Research. <year>2017</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref027">
<label>27</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Yin</surname><given-names>F</given-names></name>, <name><surname>Gao</surname><given-names>J</given-names></name>, <name><surname>Fan</surname><given-names>X</given-names></name>. <article-title>Association Between 5-HTTLPR Polymorphism and the Risk of Autism: A Meta-Analysis Based on Case-Control Studies</article-title>. <source/>Front psychiatry [Internet]. <year>2019</year>
<month>2</month>
<day>13</day>;<volume>10</volume>:<fpage>51</fpage>
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30814960">https://www.ncbi.nlm.nih.gov/pubmed/30814960</ext-link>
<pub-id pub-id-type="pmid">30814960</pub-id></mixed-citation>
</ref>
<ref id="pone.0235512.ref028">
<label>28</label>
<mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>CH</given-names></name>, <name><surname>Santangelo</surname><given-names>SL</given-names></name>. <article-title>Autism and serotonin transporter gene polymorphisms: A systematic review and meta-analysis</article-title>. <source/>American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. <year>2008</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref029">
<label>29</label>
<mixed-citation publication-type="journal"><name><surname>Sleeswijk</surname><given-names>AW</given-names></name>, <name><surname>Heijungs</surname><given-names>R</given-names></name>, <name><surname>Durston</surname><given-names>S</given-names></name>. <article-title>Tackling missing heritability by use of an optimum curve: A systematic review and meta-analysis</article-title>. <source/>Int J Mol Sci. <year>2019</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref030">
<label>30</label>
<mixed-citation publication-type="journal"><name><surname>Lord</surname><given-names>C</given-names></name>, <name><surname>Rutter</surname><given-names>M</given-names></name>, <name><surname>Goode</surname><given-names>S</given-names></name>, <name><surname>Heemsbergen</surname><given-names>J</given-names></name>, <name><surname>Jordan</surname><given-names>H</given-names></name>, <name><surname>Mawhood</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Austism diagnostic observation schedule: A standardized observation of communicative and social behavior</article-title>. <source/>J Autism Dev Disord. <year>1989</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref031">
<label>31</label>
<mixed-citation publication-type="journal"><name><surname>Lord</surname><given-names>C</given-names></name>, <name><surname>Risi</surname><given-names>S</given-names></name>, <name><surname>Lambrecht</surname><given-names>L</given-names></name>, <name><surname>Cook</surname><given-names>EH</given-names></name>, <name><surname>Leventhal</surname><given-names>BL</given-names></name>, <name><surname>Dilavore</surname><given-names>PC</given-names></name>, <etal>et al</etal>
<article-title>The Autism Diagnostic Observation Schedule-Generic: A standard measure of social and communication deficits associated with the spectrum of autism</article-title>. <source/>J Autism Dev Disord. <year>2000</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref032">
<label>32</label>
<mixed-citation publication-type="journal"><name><surname>Lord</surname><given-names>C</given-names></name>, <name><surname>Rutter</surname><given-names>M</given-names></name>, <name><surname>Le Couteur</surname><given-names>A</given-names></name>. <article-title>Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders</article-title>. <source/>J Autism Dev Disord. <year>1994</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref033">
<label>33</label>
<mixed-citation publication-type="journal"><name><surname>Petri</surname><given-names>S</given-names></name>, <name><surname>Riederer</surname><given-names>P</given-names></name>, <name><surname>Heils</surname><given-names>A</given-names></name>, <name><surname>Lesch</surname><given-names>KP</given-names></name>, <name><surname>Bengel</surname><given-names>D</given-names></name>, <name><surname>Stober</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Allelic variation of human serotonin transporter gene expression</article-title>. <source/>J Neurochem. <year>1996</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref034">
<label>34</label>
<mixed-citation publication-type="journal"><name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Liberati</surname><given-names>A</given-names></name>, <name><surname>Tetzlaff</surname><given-names>J AD</given-names></name>. <article-title>PRISMA 2009 Flow Diagram</article-title>. <source/>The PRISMA statement. <year>2009</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref035">
<label>35</label>
<mixed-citation publication-type="journal"><name><surname>Purcell</surname><given-names>S</given-names></name>, <name><surname>Neale</surname><given-names>B</given-names></name>, <name><surname>Todd-Brown</surname><given-names>K</given-names></name>, <name><surname>Thomas</surname><given-names>L</given-names></name>, <name><surname>Ferreira</surname><given-names>MAR</given-names></name>, <name><surname>Bender</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>PLINK: A tool set for whole-genome association and population-based linkage analyses</article-title>. <source/>Am J Hum Genet. <year>2007</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref036">
<label>36</label>
<mixed-citation publication-type="journal"><source/>R Foundation for Statistical Computing. R: a Language and Environment for Statistical Computing. <ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link>. <year>2018</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref037">
<label>37</label>
<mixed-citation publication-type="journal"><name><surname>Ospina-Duque</surname><given-names>J</given-names></name>, <name><surname>Duque</surname><given-names>C</given-names></name>, <name><surname>Carvajal-Carmona</surname><given-names>L</given-names></name>, <name><surname>Ortiz-Barrientos</surname><given-names>D</given-names></name>, <name><surname>Soto</surname><given-names>I</given-names></name>, <name><surname>Pineda</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia</article-title>. <source/>Neurosci Lett. <year>2000</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref038">
<label>38</label>
<mixed-citation publication-type="journal"><name><surname>Pérez-Olmos</surname><given-names>I</given-names></name>, <name><surname>Bustamante</surname><given-names>D</given-names></name>, <name><surname>Ibáñez-Pinilla</surname><given-names>M</given-names></name>. <article-title>Serotonin transporter gene (5-HTT) polymorphism and major depressive disorder in patients in bogotá, Colombia</article-title>. <source/>Biomedica. <year>2016</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref039">
<label>39</label>
<mixed-citation publication-type="journal"><name><surname>Ramos</surname><given-names>LR</given-names></name>, <name><surname>Arias</surname><given-names>DG</given-names></name>, <name><surname>Salazar</surname><given-names>LS</given-names></name>, <name><surname>Vélez</surname><given-names>JP</given-names></name>, <name><surname>Pardo</surname><given-names>SL</given-names></name>. <article-title>Polimorfismos en el gen del transportador de serotonina (SLC6A4) y el trastorno afectivo bipolar en dos centros regionales de salud mental del Eje Cafetero*</article-title>. <source/>Rev Colomb Psiquiatr. <year>2012</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref040">
<label>40</label>
<mixed-citation publication-type="journal"><name><surname>Escobar</surname><given-names>CH</given-names></name>, <name><surname>Calderón</surname><given-names>JH</given-names></name>, <name><surname>Moreno</surname><given-names>GA</given-names></name>. <article-title>Allelic polymorphism in the serotonin transporter gene in major depression patients TT—Polimorfismos alélicos del gen del transportador de serotonina en pacientes con depresión mayor</article-title>. <source/>Colomb Med. <year>2011</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref041">
<label>41</label>
<mixed-citation publication-type="journal"><name><surname>Camarena</surname><given-names>B</given-names></name>, <name><surname>Rinetti</surname><given-names>G</given-names></name>, <name><surname>Cruz</surname><given-names>C</given-names></name>, <name><surname>Hernández</surname><given-names>S</given-names></name>, <name><surname>Ramón De La Fuente</surname><given-names>J</given-names></name>, <name><surname>Nicolini</surname><given-names>H</given-names></name>. <article-title>Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder</article-title>. <source/>Int J Neuropsychopharmacol. <year>2001</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref042">
<label>42</label>
<mixed-citation publication-type="journal"><name><surname>Peralta-Leal</surname><given-names>V</given-names></name>, <name><surname>Leal-Ugarte</surname><given-names>E</given-names></name>, <name><surname>Meza-Espinoza</surname><given-names>JP</given-names></name>, <name><surname>Gutiérrez-Angulo</surname><given-names>M</given-names></name>, <name><surname>Hernández-Benítez</surname><given-names>CT</given-names></name>, <name><surname>García-Rodríguez</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Association of serotonin transporter gene polymorphism 5-HTTLPR and depressive disorder in a Mexican population</article-title>. <source/>Psychiatric Genetics. <year>2012</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref043">
<label>43</label>
<mixed-citation publication-type="journal"><name><surname>Durán-González</surname><given-names>J</given-names></name>, <name><surname>Leal-Ugarte</surname><given-names>E</given-names></name>, <name><surname>Cruz-Alcalá</surname><given-names>LE</given-names></name>, <name><surname>Gutiérrez-Angulo</surname><given-names>M</given-names></name>, <name><surname>Gallegos-Arreola</surname><given-names>MP</given-names></name>, <name><surname>Meza-Espinoza</surname><given-names>JP</given-names></name>, <etal>et al</etal>
<article-title>Association of the SLC6A4 gene 5HTTLPR polymorphism and ADHD with epilepsy, gestational diabetes, and parental substance abuse in Mexican mestizo children</article-title>. <source/>Salud Ment. <year>2018</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref044">
<label>44</label>
<mixed-citation publication-type="journal"><name><surname>Sarmiento-Hernandez</surname><given-names>EI</given-names></name>, <name><surname>Ulloa-Flores</surname><given-names>RE</given-names></name>, <name><surname>Camarena-Medellin</surname><given-names>B</given-names></name>, <name><surname>Sanabrais-Jimenez</surname><given-names>MA</given-names></name>, <name><surname>Aguilar-Garcia</surname><given-names>A</given-names></name>, <name><surname>Hernandez-Munoz</surname><given-names>S</given-names></name>. <article-title>Association between 5-HTTLPR polymorphism, suicide attempt and comorbidity in Mexican adolescents with major depressive disorder</article-title>. <source/>Actas Esp Psiquiatr. <year>2019</year>
<month>1</month>;<volume>47</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="pmid">30724325</pub-id></mixed-citation>
</ref>
<ref id="pone.0235512.ref045">
<label>45</label>
<mixed-citation publication-type="journal"><name><surname>Cajal</surname><given-names>AR</given-names></name>, <name><surname>Redal</surname><given-names>MA</given-names></name>, <name><surname>Costa</surname><given-names>LD</given-names></name>, <name><surname>Lesik</surname><given-names>LA</given-names></name>, <name><surname>Faccioli</surname><given-names>JL</given-names></name>, <name><surname>Finkelsztein</surname><given-names>CA</given-names></name>, <etal>et al</etal>
<article-title>Influence of 5-HTTLPR and 5-HTTVNTR polymorphisms of the serotonin transporter gene (SLC6A4) on major depressive disorder in a sample of Argentinean population</article-title>. <source/>Psychiatr Genet. <year>2012</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref046">
<label>46</label>
<mixed-citation publication-type="journal"><name><surname>Neves</surname><given-names>FS</given-names></name>, <name><surname>Silveira</surname><given-names>G</given-names></name>, <name><surname>Romano-Silva</surname><given-names>MA</given-names></name>, <name><surname>Malloy-Diniz</surname><given-names>L</given-names></name>, <name><surname>Ferreira</surname><given-names>AA</given-names></name>, <name><surname>De Marco</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Is the 5-HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients?</article-title>
<source/>Am J Med Genet Part B Neuropsychiatr Genet. <year>2008</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref047">
<label>47</label>
<mixed-citation publication-type="journal"><name><surname>Mendes De Oliveira</surname><given-names>JR</given-names></name>, <name><surname>Otto</surname><given-names>PA</given-names></name>, <name><surname>Vallada</surname><given-names>H</given-names></name>, <name><surname>Lauriano</surname><given-names>V</given-names></name>, <name><surname>Elkis</surname><given-names>H</given-names></name>, <name><surname>Lafer</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia</article-title>. <source/>Am J Med Genet—Neuropsychiatr Genet. <year>1998</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref048">
<label>48</label>
<mixed-citation publication-type="journal"><name><surname>Oliveira</surname><given-names>JRM</given-names></name>, <name><surname>Carvalho</surname><given-names>DR</given-names></name>, <name><surname>Pontual</surname><given-names>D</given-names></name>, <name><surname>Gallindo</surname><given-names>RM</given-names></name>, <name><surname>Sougey</surname><given-names>EB</given-names></name>, <name><surname>Gentil</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Analysis of the serotonin transporter polymorphism (5-HTTLPR) in Brazilian patients affected by dysthymia, major depression and bipolar disorder</article-title>. <source/>Molecular Psychiatry. <year>2000</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref049">
<label>49</label>
<mixed-citation publication-type="journal"><name><surname>Bortoluzzi</surname><given-names>A</given-names></name>, <name><surname>Blaya</surname><given-names>C</given-names></name>, <name><surname>Salum</surname><given-names>GA</given-names></name>, <name><surname>Cappi</surname><given-names>C</given-names></name>, <name><surname>Leistner-Segal</surname><given-names>S</given-names></name>, <name><surname>Manfro</surname><given-names>GG</given-names></name>. <article-title>Anxiety disorders and anxiety-related traits and serotonin transporter gene-linked polymorphic region (5-HTTLPR) in adolescents: Case-control and trio studies</article-title>. <source/>Psychiatr Genet. <year>2014</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref050">
<label>50</label>
<mixed-citation publication-type="journal"><name><surname>Segal</surname><given-names>J</given-names></name>, <name><surname>Pujol</surname><given-names>C</given-names></name>, <name><surname>Birck</surname><given-names>A</given-names></name>, <name><surname>Gus Manfro</surname><given-names>G</given-names></name>, <name><surname>Leistner-Segal</surname><given-names>S</given-names></name>. <article-title>Association between suicide attempts in south Brazilian depressed patients with the serotonin transporter polymorphism</article-title>. <source/>Psychiatry Res. <year>2006</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref051">
<label>51</label>
<mixed-citation publication-type="journal"><name><surname>Schenkel</surname><given-names>LC</given-names></name>, <name><surname>Bragatti</surname><given-names>JA</given-names></name>, <name><surname>Torres</surname><given-names>CM</given-names></name>, <name><surname>Martin</surname><given-names>KC</given-names></name>, <name><surname>Manfro</surname><given-names>GG</given-names></name>, <name><surname>Leistner-Segal</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Serotonin transporter gene (5HTT) polymorphisms and temporal lobe epilepsy</article-title>. <source/>Epilepsy Res. <year>2011</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref052">
<label>52</label>
<mixed-citation publication-type="journal"><name><surname>Longo</surname><given-names>D</given-names></name>, <name><surname>Schüler-Faccini</surname><given-names>L</given-names></name>, <name><surname>Brandalize</surname><given-names>APC</given-names></name>, <name><surname>dos Santos Riesgo</surname><given-names>R</given-names></name>, <name><surname>Bau</surname><given-names>CHD</given-names></name>. <article-title>Influence of the 5-HTTLPR polymorphism and environmental risk factors in a Brazilian sample of patients with autism spectrum disorders</article-title>. <source/>Brain Res. <year>2009</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref053">
<label>53</label>
<mixed-citation publication-type="journal"><name><surname>Krelling</surname><given-names>R</given-names></name>, <name><surname>Cordeiro</surname><given-names>Q</given-names></name>, <name><surname>Miracca</surname><given-names>E</given-names></name>, <name><surname>Gutt</surname><given-names>EK</given-names></name>, <name><surname>Petresco</surname><given-names>S</given-names></name>, <name><surname>Moreno</surname><given-names>RA</given-names></name>, <etal>et al</etal>
<article-title>Molecular genetic case-control women investigation from the first Brazilian high-risk study on functional psychosis</article-title>. <source/>Rev Bras Psiquiatr. <year>2008</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref054">
<label>54</label>
<mixed-citation publication-type="journal"><name><surname>Meira-Lima</surname><given-names>I</given-names></name>, <name><surname>Shavitt</surname><given-names>RG</given-names></name>, <name><surname>Miguita</surname><given-names>K</given-names></name>, <name><surname>Ikenaga</surname><given-names>E</given-names></name>, <name><surname>Miguel</surname><given-names>EC</given-names></name>, <name><surname>Vallada</surname><given-names>H</given-names></name>. <article-title>Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder</article-title>. <source/>Genes, Brain Behav. <year>2004</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref055">
<label>55</label>
<mixed-citation publication-type="journal"><name><surname>Kenna</surname><given-names>GA</given-names></name>, <name><surname>Roder-Hanna</surname><given-names>N</given-names></name>, <name><surname>Leggio</surname><given-names>L</given-names></name>, <name><surname>Zywiak</surname><given-names>WH</given-names></name>, <name><surname>Clifford</surname><given-names>J</given-names></name>, <name><surname>Edwards</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: Review of psychopathology and pharmacotherapy</article-title>. <source/>Pharmacogenomics and Personalized Medicine. <year>2012</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref056">
<label>56</label>
<mixed-citation publication-type="journal"><name><surname>Valencia</surname><given-names>AV</given-names></name>, <name><surname>Páez</surname><given-names>AL</given-names></name>, <name><surname>Sampedro</surname><given-names>ME</given-names></name>, <name><surname>Ávila</surname><given-names>C</given-names></name>, <name><surname>Cardona</surname><given-names>JC</given-names></name>, <name><surname>Mesa</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Evidencia de asociación entre el gen SLC6A4 y efectos epistáticos con variantes en HTR2A en la etiología del autismo en la población antioqueña</article-title>. <source/>Biomedica. <year>2012</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref057">
<label>57</label>
<mixed-citation publication-type="journal"><name><surname>Tordjman</surname><given-names>S</given-names></name>, <name><surname>Gutknecht</surname><given-names>L</given-names></name>, <name><surname>Carlier</surname><given-names>M</given-names></name>, <name><surname>Spitz</surname><given-names>E</given-names></name>, <name><surname>Antoine</surname><given-names>C</given-names></name>, <name><surname>Slama</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Role of the serotonin transporter gene in the behavioral expression of autism</article-title>. <source/>Mol Psychiatry. <year>2001</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref058">
<label>58</label>
<mixed-citation publication-type="journal"><name><surname>Brune</surname><given-names>CW</given-names></name>, <name><surname>Kim</surname><given-names>SJ</given-names></name>, <name><surname>Salt</surname><given-names>J</given-names></name>, <name><surname>Leventhal</surname><given-names>BL</given-names></name>, <name><surname>Lord</surname><given-names>C</given-names></name>, <name><surname>Cook</surname><given-names>EH</given-names></name>. <article-title>5-HTTLPR genotype-specific phenotype in children and adolescents with autism</article-title>. <source/>Am J Psychiatry. <year>2006</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref059">
<label>59</label>
<mixed-citation publication-type="journal"><name><surname>Gadow</surname><given-names>KD</given-names></name>, <name><surname>DeVincent</surname><given-names>CJ</given-names></name>, <name><surname>Siegal</surname><given-names>VI</given-names></name>, <name><surname>Olvet</surname><given-names>DM</given-names></name>, <name><surname>Kibria</surname><given-names>S</given-names></name>, <name><surname>Kirsch</surname><given-names>SF</given-names></name>, <etal>et al</etal>
<article-title>Allele-specific associations of 5-HTTLPR/rs25531 with ADHD and autism spectrum disorder</article-title>. <source/>Prog Neuro-Psychopharmacology Biol Psychiatry. <year>2013</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref060">
<label>60</label>
<mixed-citation publication-type="journal"><name><surname>Kolevzon</surname><given-names>A</given-names></name>, <name><surname>Newcorn</surname><given-names>JH</given-names></name>, <name><surname>Kryzak</surname><given-names>L</given-names></name>, <name><surname>Chaplin</surname><given-names>W</given-names></name>, <name><surname>Watner</surname><given-names>D</given-names></name>, <name><surname>Hollander</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Relationship between whole blood serotonin and repetitive behaviors in autism</article-title>. <source/>Psychiatry Res. <year>2010</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref061">
<label>61</label>
<mixed-citation publication-type="journal"><name><surname>Jaiswal</surname><given-names>P</given-names></name>, <name><surname>Guhathakurta</surname><given-names>S</given-names></name>, <name><surname>Singh</surname><given-names>AS</given-names></name>, <name><surname>Verma</surname><given-names>D</given-names></name>, <name><surname>Pandey</surname><given-names>M</given-names></name>, <name><surname>Varghese</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: A study from an Indian population</article-title>. <source/>Prog Neuro-Psychopharmacology Biol Psychiatry. <year>2015</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref062">
<label>62</label>
<mixed-citation publication-type="journal"><name><surname>Tassone</surname><given-names>F</given-names></name>, <name><surname>Pan</surname><given-names>R</given-names></name>, <name><surname>Amiri</surname><given-names>K</given-names></name>, <name><surname>Taylor</surname><given-names>AK</given-names></name>, <name><surname>Hagerman</surname><given-names>PJ</given-names></name>. <article-title>A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations</article-title>. <source/>J Mol Diagnostics. <year>2008</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref063">
<label>63</label>
<mixed-citation publication-type="other">Daly E, D. Tricklebank M, Wichers R. Chapter Two—Neurodevelopmental roles and the serotonin hypothesis of autism spectrum disorder. In: Tricklebank MD, Daly EBT-TSS, editors. Academic Press; 2019. p. 23–44. <ext-link ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/B9780128133231000025">http://www.sciencedirect.com/science/article/pii/B9780128133231000025</ext-link></mixed-citation>
</ref>
<ref id="pone.0235512.ref064">
<label>64</label>
<mixed-citation publication-type="journal"><name><surname>Greene</surname><given-names>CS</given-names></name>, <name><surname>Penrod</surname><given-names>NM</given-names></name>, <name><surname>Williams</surname><given-names>SM</given-names></name>, <name><surname>Moore</surname><given-names>JH</given-names></name>. <article-title>Failure to replicate a genetic association may provide important clues about genetic architecture</article-title>. <source/>PLoS One. <year>2009</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref065">
<label>65</label>
<mixed-citation publication-type="journal"><name><surname>Sirugo</surname><given-names>G</given-names></name>, <name><surname>Williams</surname><given-names>SM</given-names></name>, <name><surname>Tishkoff</surname><given-names>SA</given-names></name>. <article-title>The Missing Diversity in Human Genetic Studies</article-title>. <source/>Cell. <year>2019</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref066">
<label>66</label>
<mixed-citation publication-type="journal"><name><surname>Odgerel</surname><given-names>Z</given-names></name>, <name><surname>Talati</surname><given-names>A</given-names></name>, <name><surname>Hamilton</surname><given-names>SP</given-names></name>, <name><surname>Levinson</surname><given-names>DF</given-names></name>, <name><surname>Weissman</surname><given-names>MM</given-names></name>. <article-title>Genotyping serotonin transporter polymorphisms 5-HTTLPR and rs25531 in European- and African-American subjects from the National Institute of Mental Health’s Collaborative Center for Genomic Studies</article-title>. <source/>Transl Psychiatry. <year>2013</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref067">
<label>67</label>
<mixed-citation publication-type="journal"><name><surname>Nyffeler</surname><given-names>J</given-names></name>, <name><surname>Walitza</surname><given-names>S</given-names></name>, <name><surname>Bobrowski</surname><given-names>E</given-names></name>, <name><surname>Gundelfinger</surname><given-names>R</given-names></name>, <name><surname>Grünblatt</surname><given-names>E</given-names></name>. <article-title>Association study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism</article-title>. <source/>J Mol Psychiatry. <year>2014</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref068">
<label>68</label>
<mixed-citation publication-type="journal"><name><surname>Bondy</surname><given-names>B</given-names></name>, <name><surname>Erfurth</surname><given-names>A</given-names></name>, <name><surname>De Jonge</surname><given-names>S</given-names></name>, <name><surname>Krüger</surname><given-names>M</given-names></name>, <name><surname>Meyer</surname><given-names>H</given-names></name>. <article-title>Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide</article-title>. <source/>Mol Psychiatry. <year>2000</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref069">
<label>69</label>
<mixed-citation publication-type="journal"><name><surname>Long</surname><given-names>H</given-names></name>, <name><surname>Liu</surname><given-names>B</given-names></name>, <name><surname>Hou</surname><given-names>B</given-names></name>, <name><surname>Wang</surname><given-names>C</given-names></name>, <name><surname>Kendrick</surname><given-names>KM</given-names></name>, <name><surname>Yu</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>A potential ethnic difference in the association between 5-HTTLPR polymorphisms and the brain default mode network</article-title>. <source/>Chinese Sci Bull. <year>2014</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref070">
<label>70</label>
<mixed-citation publication-type="journal"><name><surname>Murdoch</surname><given-names>JD</given-names></name>, <name><surname>Speed</surname><given-names>WC</given-names></name>, <name><surname>Pakstis</surname><given-names>AJ</given-names></name>, <name><surname>Heffelfinger</surname><given-names>CE</given-names></name>, <name><surname>Kidd</surname><given-names>KK</given-names></name>. <article-title>Worldwide population variation and haplotype analysis at the serotonin transporter gene SLC6A4 and implications for association studies</article-title>. <source/>Biol Psychiatry. <year>2013</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref071">
<label>71</label>
<mixed-citation publication-type="journal"><name><surname>Esau</surname><given-names>L</given-names></name>, <name><surname>Kaur</surname><given-names>M</given-names></name>, <name><surname>Adonis</surname><given-names>L</given-names></name>, <name><surname>Arieff</surname><given-names>Z</given-names></name>. <article-title>The 5-HTTLPR polymorphism in South African healthy populations: A global comparison</article-title>. <source/>J Neural Transm. <year>2008</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref072">
<label>72</label>
<mixed-citation publication-type="journal"><name><surname>de Souza</surname><given-names>AM</given-names></name>, <name><surname>Resende</surname><given-names>SS</given-names></name>, <name><surname>de Sousa</surname><given-names>TN</given-names></name>, <name><surname>de Brito</surname><given-names>CFA</given-names></name>. <article-title>A systematic scoping review of the genetic ancestry of the brazilian population</article-title>. <source/>Genetics and Molecular Biology. <year>2019</year>.</mixed-citation>
</ref>
<ref id="pone.0235512.ref073">
<label>73</label>
<mixed-citation publication-type="journal"><name><surname>Gontijo</surname><given-names>CC</given-names></name>, <name><surname>Mendes</surname><given-names>FM</given-names></name>, <name><surname>Santos</surname><given-names>CA</given-names></name>, <name><surname>Klautau-Guimarães M de</surname><given-names>N</given-names></name>, <name><surname>Lareu</surname><given-names>MV</given-names></name>, <name><surname>Carracedo</surname><given-names>Á</given-names></name>, <etal>et al</etal>
<article-title>Ancestry analysis in rural Brazilian populations of African descent</article-title>. <source/>Forensic Sci Int Genet. <year>2018</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref074">
<label>74</label>
<mixed-citation publication-type="journal"><name><surname>Chor</surname><given-names>D</given-names></name>, <name><surname>Pereira</surname><given-names>A</given-names></name>, <name><surname>Pacheco</surname><given-names>AG</given-names></name>, <name><surname>Santos</surname><given-names>RV</given-names></name>, <name><surname>Fonseca</surname><given-names>MJM</given-names></name>, <name><surname>Schmidt</surname><given-names>MI</given-names></name>, <etal>et al</etal>
<article-title>Context-dependence of race self-classification: Results from a highly mixed and unequal middle-income country</article-title>. <source/>PLoS One. <year>2019</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref075">
<label>75</label>
<mixed-citation publication-type="journal"><name><surname>Ossa</surname><given-names>H</given-names></name>, <name><surname>Aquino</surname><given-names>J</given-names></name>, <name><surname>Pereira</surname><given-names>R</given-names></name>, <name><surname>Ibarra</surname><given-names>A</given-names></name>, <name><surname>Ossa</surname><given-names>RH</given-names></name>, <name><surname>Pérez</surname><given-names>LA</given-names></name>, <etal>et al</etal>
<article-title>Outlining the ancestry landscape of Colombian admixed populations</article-title>. <source/>PLoS One. <year>2016</year>;</mixed-citation>
</ref>
<ref id="pone.0235512.ref076">
<label>76</label>
<mixed-citation publication-type="journal"><name><surname>Adhikari</surname><given-names>K</given-names></name>, <name><surname>Chacón-Duque</surname><given-names>JC</given-names></name>, <name><surname>Mendoza-Revilla</surname><given-names>J</given-names></name>, <name><surname>Fuentes-Guajardo</surname><given-names>M</given-names></name>, <name><surname>Ruiz-Linares</surname><given-names>A</given-names></name>. <article-title>The Genetic Diversity of the Americas</article-title>. <source/>Annu Rev Genomics Hum Genet. <year>2017</year>.</mixed-citation>
</ref>
</ref-list>
</back>
<sub-article article-type="aggregated-review-documents" id="pone.0235512.r001">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0235512.r001</article-id>
<title-group>
<article-title>Decision Letter 0</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Novelli</surname>
<given-names>Giuseppe</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-statement>© 2020 Giuseppe Novelli</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Giuseppe Novelli</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-article ext-link-type="doi" id="rel-obj001" related-article-type="reviewed-article" xlink:href="10.1371/journal.pone.0235512"></related-article>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>0</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">12 May 2020</named-content>
</p>
<p>PONE-D-20-10849</p>
<p>The role of 5-HTTLPR polymorphism in Autism Spectrum Disorder and other psychiatric disorders in the Latin American population</p>
<p>PLOS ONE</p>
<p>Dear Dr Lattig,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>We would appreciate receiving your revised manuscript by Jun 26 2020 11:59PM. When you are ready to submit your revision, log on to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pone/">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.</p>
<p>To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link></p>
<p>Please include the following items when submitting your revised manuscript:</p>
<p>
<list list-type="bullet">
<list-item>
<p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.</p>
</list-item>
<list-item>
<p>A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.</p>
</list-item>
<list-item>
<p>An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.</p>
</list-item>
</list>
</p>
<p>Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Giuseppe Novelli</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
</p>
<p>2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: <ext-link ext-link-type="uri" xlink:href="https://www.youtube.com/watch?v=_xcclfuvtxQ">https://www.youtube.com/watch?v=_xcclfuvtxQ</ext-link></p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<bold>Comments to the Author</bold>
</p>
<p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>2. Has the statistical analysis been performed appropriately and rigorously? </p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <ext-link ext-link-type="uri" xlink:href="http://www.plosone.org/static/policies.action#sharing">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>5. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: In this paper, in light of the controversial evidence on the association between the 5-HTTLPR short variant (S) and 5-HTTLPR long variant (L) and ASD, the authors carried out a meta-analysis on the topic, focusing on the Colombian population.</p>
<p>The two variants fall into the promoter sequence of the SLC6A4 gene that codes for a transporter and regulator of serotonin levels, located in the presynaptic membrane.</p>
<p>The individuals were divided into two groups: the cases group consisting of 105 ASD trios, selected on the basis of the DSM-V, ADOS and ADI-R scale criteria; the control group of 171 apparently healthy unrelated individuals, from the same geographical area. After genotyping, the authors investigated the association between ASD and polymorphisms based on allelic, genotypic, dominant and recessive models. A linear regression analysis and association with quantitative traits was conducted to evaluate the association with severity for common traits for ASD. Subsequently, the results were compared with a meta-analysis on the data present in literature. In conclusion, the authors did not find a significant association between ASD and 5-HTTLPR polymorphisms in their case-control study. In addition, their meta-analysis highlighted a homogeneity of the frequency of the two variants in the Colombian population, which appears to be similar to that of the Caucasian population, but different from the African and Asian ones.</p>
<p>The article, despite its simplicity, is interesting and well-focused in the descriptive part. It would be appropriate to adapt the Discussion section accordingly, avoiding elements of repetitiveness, in order to make the reading more smooth and pleasant.</p>
<p>According to the Preferred Reporting Items for Systematic Review and Meta-analysis statement (PRISMA checklist 2009) we suggest revising the title to introduce a statement regarding meta-analysis work.</p>
<p>It might be useful to describe the information sources including databases’ dates of coverage and eventual contact with study authors. Aiming for a stronger significance of the results, we suggest to include any assessment of publication bias and to describe the methods used to investigate the presence of missing studies. We also recommend specifying whether duplicates have been found. If so, the authors might want to insert the duplicates exclusion step in the flow chart (S1 Figure) in the screening section.</p>
<p>In the text line 119, the information in the first parenthesis “(S vs )” seems to be incomplete.</p>
<p>In the text lines 130-133, we recommend the substitution of the term “synapsis” (that is the pairing of homologous chromosomes during the first prophase of meiosis) with the term “synapse”. We also recommend to rephrase the sentence from text line 132 to 133.</p>
<p>The main points are consistent with the analysis carried out. The tables are easy to interpret and the discussion does not highlight major issues.</p>
<p>However, the cohort under examination is reduced in number, therefore it cannot be considered statistically strong, as reported by the authors. The results could also be affected by stratification in the population under examination.</p>
<p>Reviewer #2: This study is a case-control analysis whose purpose is to evaluate a possible association between S/L 5HTTLPR polymorphism and idiopathic ASD in Colombian population. Moreover, they also investigated if there is a preferential transmission of the S or L allele and if there is association between the 5HTTLPR genotype and the severity of ASD symptoms, considering three main phenotypic traits (social communication, Restricted/repetitive behaviors and Social interaction) evaluated through ADOS scale. For a deeper analysis in comparison with the current scientific findings on this topic, three databases were consulted for a literature search: PubMed, ScienceDirect and Scielo. Among the results, 17 case-control studies fitted the inclusion criteria.</p>
<p>5-HTTLPR polymorphism was screened through PCR in 105 individuals with diagnosis of Idiopathic ASD and 171 unrelated and unaffected individuals belonging to the same region. The polymorphism was evaluated under the allelic (L VS S), genotypic (SS vs LS vs LL), dominant (LL/LS vs SS) and recessive (SS vs LS/LL) models. No significant association was found between 5-HTTLPR and ASD (after Bonferroni’s correction) [table 1]. The family-based association between the genotype and ASD in the 105 trios was evaluated with TDT test, resulting in no preferential transmission of either the S or L allele.</p>
<p>Regarding the association between ASD core symptoms severity and 5-HTTLPR according to genotype, none was found using statistical tests [table 2].</p>
<p>They also conducted a meta-analysis evaluating 5-HTTLPR polymorphism in Latin American population and its relation with psychiatric disorders[table 3; figure 1], resulting in no significant association.</p>
<p>As pointed out by the author, there are already three meta-analysis that demonstrate that the S/L 5HTTLPR polymorphism is not a risk factor for ASD, however this work has also taken into account the ethnical heterogeneity as a factor of influence. Through the meta-analysis they showed also that the frequency of L/S alleles is in the Latin-American population is quite similar to the reported frequency for Caucasian population (thus quite homogeneous). Due to conflicting results in other studies, it is yet to be confirmed if 5-HTTLPR polymorphism actually varies between ethnicities and if the genetic background of each population may have a role in the risk conferred by this polymorphism [27;28;29].</p>
<p>I think this work is interesting and able to offer a more comprehensive point of view about the relation between ASD and 5-HTTLPR polymorphism, especially of course in Latin American population.</p>
<p>All the tables presented are clear and easy to comprehend.</p>
<p>The principal Flaw I personally found in the article, was how the “Discussion” section was constructed.</p>
<p>Some topics were actually proposed more than once, rather than being articulated cohesively. For example, while explaining the preferential transmission of L or S alleles: lines 140-144 vs lines 176-178 (in association with ethnicity).</p>
<p>Some sentences are a little bit redundant and could have been better formulated, like: “Comparing our frequencies with… of the L allele” (lines: 194-198).</p>
<p>At line 119 there is a letter missing: (S vs L*).</p>
<p>**********</p>
<p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: No</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
</body>
</sub-article>
<sub-article article-type="author-comment" id="pone.0235512.r002">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0235512.r002</article-id>
<title-group>
<article-title>Author response to Decision Letter 0</article-title>
</title-group>
<related-article ext-link-type="doi" id="rel-obj002" related-article-type="editor-report" xlink:href="10.1371/journal.pone.0235512"></related-article>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="author-response-date">2 Jun 2020</named-content>
</p>
<p>We appreciate the careful reading and the provided feedback on the manuscript “The role of 5-HTTLPR polymorphism in Autism Spectrum Disorder and other psychiatric disorders in the Latin American population”. We changed the original title to “The role of 5-HTTLPR in autism spectrum disorder: New evidence and a Meta-Analysis of this polymorphism in Latin American population with psychiatric disorders”. We incorporated suggestions made by the reviewers and editor with track changes in the “Revised Manuscript with track changes” and answer them below:</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. </p>
<p>A/ We adjusted the revised manuscript file according to PlosOne requirements.</p>
<p>We also included new tables (S1, S2 and S3 Tables) to fulfill publicly available information belonging to this manuscript. S1 Table includes genotypic information of trios and ADIR and ADOS scores for each individual with ASD. S2 Table has the genotypic information of controls. The S3 table includes the statistical results for each model.</p>
<p>2. PLOS requires an ORCID D for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. </p>
<p>A/ We included the ORCID ID of the corresponding author as follows <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-2113-9266">https://orcid.org/0000-0003-2113-9266</ext-link>
</p>
<p>Additionally, while reviewing the prisma checklist we encountered an article that contained all the genetic data but was initially excluded because it did not contain Hardy-Weinberg information. With the information provided by the authors in the article it was possible for us to obtain the HW results and therefore include it in our study. The results with the new information did not change the overall results </p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>Comments to the Author</p>
<p> Reviewer # 1: </p>
<p>1. The article, despite its simplicity, is interesting and well-focused in the descriptive part. It would be appropriate to adapt the Discussion section accordingly, avoiding elements of repetitiveness, in order to make the reading more smooth and pleasant.</p>
<p>According to the Preferred Reporting Items for Systematic Review and Meta-analysis statement (PRISMA checklist 2009) we suggest revising the title to introduce a statement regarding meta-analysis work.</p>
<p>A/ We appreciate your comments, they are very helpful and aimed to improve the quality of our work. _The original tittle “The role of 5-HTTLPR polymorphism in Autism Spectrum Disorder and other psychiatric disorders in the Latin American population” was modified to “The role of 5-HTTLPR in autism spectrum disorder: New evidence and a Meta-Analysis of this polymorphism in Latin American population with psychiatric disorders” to include the meta-analysis performed </p>
<p>2. It might be useful to describe the information sources including databases’ dates of coverage and eventual contact with study authors. Aiming for a stronger significance of the results, we suggest to include any assessment of publication bias and to describe the methods used to investigate the presence of missing studies. We also recommend specifying whether duplicates have been found. If so, the authors might want to insert the duplicates exclusion step in the flow chart (S1 Figure) in the screening section.</p>
<p>A/ We included the PRISMA checklist 2009 that contains information regarding dates, number of duplicated studies and authors contact in the paragraph of “Literature search”. Moreover, the paragraph “Statistical analysis” was modified to include the methodology used to evaluate for publication bias (Funnel plots, Egger’s / Begg’s tests) and the presence of missing studies (Trim and fill method). </p>
<p>A sensitivity assessment was also included to evaluate a risk of bias within selected studies. </p>
<p>The section Literature Search and Statistical Analysis was modified to include all these aspects. </p>
<p>3.In the text line 119, the information in the first parenthesis “(S vs )” seems to be incomplete.</p>
<p>A/The L letter was added to correct this mistake. </p>
<p>4. In the text lines 130-133, we recommend the substitution of the term “synapsis” (that is the pairing of homologous chromosomes during the first prophase of meiosis) with the term “synapse”. We also recommend to rephrase the sentence from text line 132 to 133.</p>
<p>A/We substituted the “Synapsis” by “Synapse” term. Moreover, we rephrased the next sentence for better understanding. </p>
<p>Reviewer #2: </p>
<p>1. I think this work is interesting and able to offer a more comprehensive point of view about the relation between ASD and 5-HTTLPR polymorphism, especially of course in Latin American population. All the tables presented are clear and easy to comprehend.</p>
<p>2. The principal Flaw I personally found in the article, was how the “Discussion” section was constructed. Some topics were actually proposed more than once, rather than being articulated cohesively. For example, while explaining the preferential transmission of L or S alleles: lines 140-144 vs lines 176-178 (in association with ethnicity). Some sentences are a little bit redundant and could have been better formulated, like: “Comparing our frequencies with… of the L allele” (lines: 194-198).</p>
<p>A/We appreciate your comments, they are very helpful and aimed to improve the quality of our work. We removed repetitive information previously consigned in these paragraphs and rephrased sentences to provide a better formulation of this information.</p>
<p>3. At line 119 there is a letter missing: (S vs L*).</p>
<p>A/The L letter was added to correct this mistake.</p>
<supplementary-material content-type="local-data" id="pone.0235512.s013">
<label>Attachment</label>
<caption>
<p>Submitted filename: <named-content content-type="submitted-filename">Response reviewer.docx</named-content></p>
</caption>
<media xlink:href="pone.0235512.s013.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pone.0235512.r003">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0235512.r003</article-id>
<title-group>
<article-title>Decision Letter 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Novelli</surname>
<given-names>Giuseppe</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-statement>© 2020 Giuseppe Novelli</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Giuseppe Novelli</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-article ext-link-type="doi" id="rel-obj003" related-article-type="reviewed-article" xlink:href="10.1371/journal.pone.0235512"></related-article>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">17 Jun 2020</named-content>
</p>
<p>The role of 5-HTTLPR in autism spectrum disorder: New evidence and a Meta-Analysis of this polymorphism in Latin American population with psychiatric disorders</p>
<p>PONE-D-20-10849R1</p>
<p>Dear Dr. Lattig,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link ext-link-type="uri" xlink:href="http://www.editorialmanager.com/pone/">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
<p>Kind regards,</p>
<p>Giuseppe Novelli</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>Reviewers' comments:</p>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pone.0235512.r004">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0235512.r004</article-id>
<title-group>
<article-title>Acceptance letter</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Novelli</surname>
<given-names>Giuseppe</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-statement>© 2020 Giuseppe Novelli</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Giuseppe Novelli</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-article ext-link-type="doi" id="rel-obj004" related-article-type="reviewed-article" xlink:href="10.1371/journal.pone.0235512"></related-article>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">23 Jun 2020</named-content>
</p>
<p>PONE-D-20-10849R1 </p>
<p>The role of 5-HTTLPR in autism spectrum disorder: New evidence and a Meta-Analysis of this polymorphism in Latin American population with psychiatric disorders </p>
<p>Dear Dr. Lattig:</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p>
<p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p>
<p>If we can help with anything else, please email us at <email>plosone@plos.org</email>. </p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
<p>Kind regards, </p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Prof. Giuseppe Novelli </p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
</body>
</sub-article>
</article>
</pmc-articleset>